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Executive summary 
In this report it is evaluated whether nickel, mineral oil, poly aromatic hydrocarbons (PAHs) and 
volatile organic compounds (VOCs) should be included in the National Control Plan for Animal Feed. 
To date, no maximum permitted levels have been established for these (groups of) compounds, so 
there is no regulatory basis for inclusion of the compounds in the monitoring. To evaluate whether 
inclusion is necessary to ensure safety of food producing animals and consumers of animal products, 
risk assessments were performed. For this, toxicological profiles of the compounds were made for 
hazard characterization, and subsequently data from the National Control Plan for Animal Feed (years 
2000-2004) were used for scenario calculations to estimate the potential risks. For PAHs, additional 
information on PAH carry-over from the report ‘Voorkomen van PAK’s in voer, omgeving van dieren, 
melk en zuivelproducten alsmede een oriënterende studie in melkvee’ of Kan et al (2003) was used. 
The risk assessments are presented per (group of) compound(s) in this report. 
 
The recommendations as regards to inclusion of compounds in the National Control Plan for Animal 
Feed are: 
• Not to include nickel, mineral oils or VOCs  in the National Control Plan for Animal Feed. 
• To include PAHs in the National Control Plan for Animal Feed 
 
From the risk assessments, the following points of interest can be summarized: 
 
Nickel in mineral supplements 
Nickel is used in food production as a catalyzing agent in vegetable oil refinery. Residues of this use in 
food are not expected to pose a risk to consumers. The total daily oral intake has been estimated by 
EFSA (2005) to be at the level of the lowest TDI found. The predominant oral nickel exposure of 
humans can be mainly attributed to the consumption of plants contaminated with nickel. Since the 
expected contribution of nickel originating from animal feed to the daily intake by consumers was 
expected to be very low, no further risk assessment was performed. The possible risk to animal health 
could not be estimated because no information was available on the amounts of mineral feed 
supplements used in animal husbandry.  
Recommendations: 
• To gather information on the use of mineral feed supplements in animal husbandry. 
 
Mineral oils 
Food grade mineral oils, or hydrocarbons, are produced as by-products during the refining and 
distillation of crude mineral oils. In practice, several definitions for mineral oils are used. For this risk 
assessment, only the aliphatic (straight) alkanes with carbon numbers between 10 and 40 were 
considered. The risk assessment was severely hampered by the fact that the TDIs for mineral oils are 
specified for the separate alkane fractions, while the results of the analysis of hydrocarbons in food or 
feed are usually expressed as (general) alkanes. 
The main toxicological effect following oral exposure was the appearance of microgranoluma in 
mesenterial lymph nodes, but only in one species of rats. Similar phenomena have been observed in 
humans after oral exposure to mineral oils. Much controversy on the subject of the toxicological 
relevance of this effect exists. The implication of oral exposure to mineral oils for human health could 
therefore not be determined.  
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It was found that alkanes may carry over to meat, contrary to the general assumption that alkanes are 
not transferred from feed to animal products. Intake assessment indicated that risks for animal health 
could not be excluded.  
Recommendations: 
• To repeat the risk assessment if new information indicating the relevance of the effects of exposure 
to mineral oil on mesenterial lymph nodes to human health becomes available. 
 
Polyaromatic hydrocarbons (PAHs) 
Animal feed materials may contain elevated concentrations of PAHs due to environmental 
contamination or through direct drying processes. Although very little data are available on carry-over 
rates, it is generally assumed that PAHs are not transferred from animal feed to animal products such 
as milk. In this report, it is shown that contrary to this assumption, certain PAHs are transferred as 
native compounds to milk, in particular those PAHs with less than five aromatic rings. Furthermore, 
there is evidence that indicate that metabolites of some PAHs are transferred to milk, which is of 
interest because the carcinogenic properties of PAHs can be contributed to the PAH metabolites.  
Several (worst case) exposure scenarios were calculated, using the maximum measured PAH 
concentrations from the National Control Plan for Animal Feed and (limited) carry-over rates available 
from literature. The results indicate that the intake of PAHs by cattle can be in the mg-range. 
Calculated intake of PAHs by humans via milk is at least a factor 1000 under the chronic Reference 
Dose (RfD) for non-carcinogenic effects. In contrast, calculated intake by humans of high-molecular 
(carcinogenic) PAHs calculated to be present in milk exceeded the ‘virtually safe dose’ for 
Benzo(a)Pyrene in several worst case scenarios. Although the scenarios are worst case in regard to the 
use of maximum measured concentrations, not all feed ingredient categories were represented in the 
dataset. This incomplete calculation results in this way in underestimating the intake assessment of 
PAHs. 
The occurrence of metabolites of PAHs has not been considered in monitoring programs of animal 
products yet. Considering their expected carcinogenicity, this is an urgent matter of attention. 
Recommendations: 
• To gather more information on carry-over of PAHs and their metabolites from feed to milk and 
other animal products 
• To incorporate toxicity of possible transferred (toxic) metabolites in risk assessment 
• To include feed ingredient categories in the monitoring of animal feed which contribute largely to 
the feeding regime. 
 
Volatile organic compounds (VOCs) 
VOCs are simple hydrocarbons that originate from crude oil and derived products. In food production, 
they are mainly used as solvents for extracting oil from oilseeds, which may result in residues in food 
and feed ingredients. Very little oral toxicity data are available on these compounds. A worst case 
scenario using maximum measured concentrations of VOCs (which will be reduced during processing 
of ingredients to compound feed) and 100% (unrealistic) carry-over from feed to animal products does 
not result in calculated intake by humans above the known reference limits. The scenario is 
overestimating exposure in view of the expectation that the concentrations of VOCs are reduced 
during processing of ingredients to compound feed and that 100% transfer is unrealistic. However, not 
all feed ingredient categories were sampled and could not be included in the calculation. 
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It is not known to what extent (toxic) metabolites of VOCs are formed and carried over to animal 
products, therefore the risk from intake of metabolites could not be excluded. A quantitative intake 
assessment for food producing animals indicated that animal health effects may occur. 
Recommendations: 
• To gather data on VOC concentrations in compound feed end product in order to perform a new 
risk assessment aimed at animal health 
• For risk assessment purposes, gather more information on formation and carry-over of toxic VOC 
metabolites from feed to milk and other animal products 
 
General 
• From the risk assessments of PAHs and VOCs it can be concluded that carry-over of metabolites 
of compounds present in animal feed to animal products needs attention. Usually, only parent 
compounds are monitored in animal products.  
• In monitoring more attention should be given to the amounts of (types of) feed consumed by the 
animal. Feed ingredient categories which are not regarded as ‘risk materials’ for certain 
compounds but cover a large part of the total feeding regime, may still add significantly to the 
total intake of contaminants. For accurate risk assessment, concentrations in these ingredients 
should be known. 
• As defined by regulation 1831/2003, processing aids are allowed to be used in feed production as 
long as residues in feed do no pose a risk for animals or humans. As shown in the case of VOCs, 
oral toxicity data may not be available to prove the lack of toxic effects. This may result in 
undesirable compounds to be used in feed production. As regards processing aids, the question 
may therefore be posed if the Regulation is fully effective in protecting human and/or animal 
health. 
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Samenvatting 
In dit rapport is geëvalueerd of nikkel, minerale olie, polyaromatische koolwaterstoffen (PAKs) en 
vluchtige organische verbindingen (VOCs) opgenomen zouden moeten worden in het Nationaal Plan 
voor contaminanten in diervoeder. Omdat er tot op heden geen maximum limieten zijn vastgesteld 
voor deze (groepen van) stoffen, ontbreekt de wettelijke basis hiervoor. Om te bepalen of monitoring 
van deze stoffen nodig is voor de bescherming van de gezondheid van landbouwhuisdieren en 
consumenten van dierlijke producten, zijn voor de stoffen risicobeoordelingen uitgevoerd. Voor het 
bepalen van mogelijke effecten zijn er toxicologische profielen opgesteld, op basis waarvan bepaald is 
of het uitvoeren van een oriënterende risicobeoordeling met data uit het Nationaal Plan voor 
Diervoeders zinvol is. Hiervoor zijn data gebruikt uit de jaren 2000-2004. Voor PAKs zijn er 
aanvullende data met betrekking tot overdracht gebruikt uit het rapport 'Voorkomen van PAKs in voer, 
omgeving van dieren, melk en zuivelproducten alsmede een oriënterende studie in melkvee' van Kan 
et al. (2003). De risicobeoordelingen zijn in dit rapport weergegeven per (groep van) stof(fen). 
 
De aanbevelingen ten aanzien van het opnemen van de stoffen in het Nationaal Plan voor Diervoeders 
zijn: 
• Het niet opnemen van nikkel, mineral olie of VOCs  in het Nationaal Plan voor Diervoeders 
• Het opnemen van PAKs in het Nationaal Plan voor Diervoeders 
 
Uit de risicobeoordeling komen de volgende aandachtspunten naar voren: 
 
Nikkel in mineralenmengsels 
In voedselproductie wordt nikkel gebruikt als katalysator in de raffinage van plantaardige vetten. Het 
is niet te verwachten dat residuen uit dit proces een risico vormen voor de consument. De totale 
dagelijkse inname is in 2005 door EFSA geschat op het niveau van de laagst gevonden grenswaarde. 
In eerdere jaren is nikkel in hoge gehalten aangetroffen in mineralenmengsels voor diervoeders. Echter 
wordt de grootste bron van inname van nikkel door de mens veroorzaakt door ophoping van nikkel in 
eetbare gewassen. Aangezien de bijdrage van nikkel in diervoeding via dierlijke producten aan de 
dagelijkse inname van consumenten naar verwachting erg laag is, is er geen verdere risicobeoordeling 
uitgevoerd voor de mens. Voor landbouwhuisdieren zou het risico anders kunnen liggen. Het risico 
voor de diergezondheid kon echter niet worden geschat omdat er geen gebruiksgegevens over 
mineralenmengsels beschikbaar waren. 
Aanbevelingen: 
• Het verzamelen van gebruiksgegevens van mineralenmengsels, zodat een betrouwbare 
risicobeoordeling van mogelijke contaminanten in de mengsels kan worden uitgevoerd. 
 
Minerale olie 
Minerale olie voor gebruik in voedsel, ook wel alkanen genoemd, worden geproduceerd als 
bijproducten tijdens het raffineren en destilleren van ruwe minerale olie. In de praktijk worden er 
verschillende definities voor minerale olie gebruikt. Voor deze risicobeoordeling worden met minerale 
olie enkel de rechte (alifatische) alkanen met ketens van 10 tot 40 C atomen bedoeld. De 
risicobeoordeling werd ernstig bemoeilijkt door het feit dat de toxicologische grenswaarden voor 
minerale olie gespecificeerd voor verschillende alkaanfracties, terwijl analyseresultaten waren 
gegeven in het totale gehalte aan alkanen.  
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Het voornaamste toxicologische effect na orale inname, is het verschijnen van microgranuloma in de 
mesenteriale lymfeklieren, maar slechts in één soort rat. Vergelijkbare verschijnselen zijn 
geconstateerd in mensen na orale toediening van minerale olie. Tot op heden is er nog geen eenduidige 
opvatting van de relevantie van dit effect voor de gezondheid. Het risico van minerale olie via inname 
van dierlijke producten voor de humane gezondheid kon daarom niet worden ingeschat. 
Een van de resultaten was dat, in tegenstelling tot wat algemeen wordt aangenomen, de mogelijkheid 
bestaat dat minerale olie vanuit diervoeder zou kunnen overdragen naar dierlijke producten (vlees). Op 
basis van berekende inname kunnen daarnaast nadelige effecten op de diergezondheid niet worden 
uitgesloten. 
Aanbevelingen: 
• De risicobeoordeling te herhalen wanneer er nieuwe inzichten zijn met betrekking tot het belang 
van de effecten van blootstelling aan minerale olie op mesenteriale lymfeklieren 
  
Polyaromatische koolwaterstoffen (PAKs) 
Ingrediënten van diervoeder kunnen verhoogde gehalten aan PAKs bevatten door 
milieuverontreiniging of door (directe) droogprocessen. Hoewel erg weinig data beschikbaar is over de 
overdrachtspercentages, wordt er in het algemeen aangenomen dat PAKs niet overdragen vanuit 
diervoeder naar dierlijke producten zoals melk. In dit onderzoek is gebleken dat in tegenstelling tot 
deze aanname, enkele PAKs wel overdragen naar melk, vooral de PAKs met minder dan vijf 
aromatische ringen. Daarnaast is gevonden dat een aantal PAKs overdragen in de vorm van 
metabolieten. Dit is van belang gezien het feit dat de carcinogene effecten van PAKs worden 
toegeschreven aan de metabolieten. 
Verscheidene worst case scenario's zijn doorgerekend met gebruik van de maximum gehalten zoals 
gemeten in het Nationaal Plan voor diervoeders, en de (enkele) overdrachtspercentages die in de 
literatuur gevonden waren. Uit de resultaten bleek dat de inname van PAKs door koeien het niveau van 
milligrammen kan bereiken. De berekende inname door mensen via melk is tenminste een factor 1000 
onder de toxicologische grenswaarden voor niet-carcinogene effecten. Daarentegen overschreed de 
berekende inname van carcinogene PAKs de 'virtually safe dose' voor Benzo(a)Pyreen. Hoewel de 
scenario's conservatief zijn vanwege het gebruik van maximum gehalten, zijn niet van alle categorieën 
diervoederingrediënten meetgegevens beschikbaar, of slechts in zeer beperkte mate. Deze onvolledige 
dataset levert weer een zekere onderschatting van de inname. 
Met overdracht van PAKs als metabolieten is tot op heden nog geen rekening gehouden in Nationaal 
Plan's voor dierlijke producten. Gezien de verwachte carcinogene werking van PAK metabolieten, is 
hun mogelijke aanwezigheid in dierlijke producten een belangrijk aandachtspunt. 
Aanbevelingen: 
• Het verzamelen van meer informatie over mogelijke overdracht van PAKs en hun metabolieten van 
diervoeder naar melk en andere dierlijke producten. 
• Het meewegen van de toxiciteit van mogelijke overgedragen metabolieten in de risicobeoordeling 
• Het opnemen van ingrediëntcategorieën die een groot aandeel beslaan van het totale 
diervoederpakket in de monitoring, ook als deze niet als risicocategorie worden aangemerkt. 
 
Vluchtige organische verbindingen (VOCs) 
VOCs zijn eenvoudige koolwaterstoffen afkomstig uit ruwe olie en de daaruit afgeleide producten. In 
voedselproductie worden VOCs voornamelijk gebruikt als extractiemiddel voor winning van olie uit 
zaden, wat kan leiden tot residuen in diervoeder en humane voedselproducten. Er is erg weinig bekend 
over toxiciteit van deze stoffen via orale blootstelling. Een worst case scenario op basis van maximum 
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gemeten concentraties en 100% overdracht van diervoeder naar dierlijke producten leidt niet tot 
overschrijding van de (weinige) toxicologische grenswaarden voor orale blootstelling. Daarnaast is het 
de verwachting dat de concentraties in de ingrediënten zullen afnemen naarmate deze verder verwerkt 
worden tot mengvoeder. Ook hier zijn niet van alle ingrediëntcategorieën meetgegevens beschikbaar. 
Het is niet bekend in hoeverre (toxische) VOC metabolieten in landbouwhuisdieren worden gevormd 
en overgedragen naar dierlijke producten, daarom kon het mogelijke risico van inname door de 
consument niet worden uitgesloten. Uit de risicobeoordeling is verder gebleken dat nadelige 
gezondheidseffecten bij landbouwhuisdieren niet zijn uitgesloten. 
Aanbevelingen: 
• Het meten van VOC concentraties in mengvoeder voor een nieuwe risicobeoordeling gericht op 
diergezondheid. 
• Het verzamelen van informatie over de vorming en overdracht van toxische metabolieten van 
VOCs in diervoeder naar dierlijke producten 
 
Algemeen 
• Uit de risicobeoordelingen van PAKs en VOCs kan geconcludeerd worden dat overdracht van 
metabolieten uit stoffen in diervoeder naar dierlijke producten aandacht behoeft. In het algemeen 
is de monitoring enkel gericht op de uitgangsstof. 
• In de monitoring zou meer rekening gehouden moeten worden met de daadwerkelijke consumptie 
van diervoederingrediënten. Categorieën die normaal gesproken niet als 'risicomaterialen' worden 
beschouwd, kunnen met een lage concentratie contaminanten toch een aanzienlijke inname 
veroorzaken doordat ze een groot gedeelte van het totale diervoederpakket omvatten. 
• Hulpstoffen zoals gedefinieerd in Verordening 1831/2003 mogen worden toegepast in de productie 
van diervoeder zolang de residuen geen gevaar vormen voor mens of dier. Zoals in het geval van 
de VOCs, kan het zijn dat er geen orale toxiciteitstudies beschikbaar zijn om nadelige effecten uit 
te kunnen sluiten. Dit zou er toe kunnen leiden dat zulke stoffen toch gebruikt worden in de 
voedselproductie. Het is daarom ten aanzien van hulpstoffen de vraag in hoeverre de Verordening 
effectief is in het beschermen van de gezondheid van mens en/of dier. 
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1 Introduction 
Contaminants from feed materials may end up in edible animal products and as such may pose a 
possible risk to consumers. The level of contamination of the Dutch animal feed is monitored by 
means of the National Control Plan for Animal Feed (following Regulation 882/2004). Up until 2005 
not only undesirable substances as defined by 2002/32/EC and amendments were included but also 
contaminants without a legal commodity limit for animal feed. The latter compounds were nickel, 
mineral oils, poly aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs). To 
evaluate if these compounds should be included in the National Control Plan for Animal Feed in future 
years and/or maximum permissable concentrations should be established, initial risk assessments were 
performed. For this, toxicological profiles of the compounds were made, and data from the National 
Control Plan for Animal Feed were used for scenario calculations. For PAHs, additional information 
on PAH carry-over from the report ‘Voorkomen van PAK’s in voer, omgeving van dieren, melk en 
zuivelproducten alsmede een oriënterende studie in melkvee’ of Kan et al (2003) was used. The risk 
assessments were performed in 2005 and 2006. 
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2 Nickel in mineral supplements 
2.1 Introduction 
Nickel is a very abundant natural element. Pure nickel is a hard, silvery-white metal. Nickel can be 
combined with other metals, such as iron, copper, chromium, and zinc, to form alloys. These alloys are 
used to make coins, jewelry, and items such as valves and heat exchangers. Most nickel is used to 
make stainless steel. 
Nickel can combine with other elements such as chlorine, sulfur, and oxygen to form nickel 
compounds. Many nickel compounds dissolve fairly easy in water and have a green color. Nickel 
compounds are used for nickel plating, to colour ceramics, to produce certain types of batteries, and as 
catalysts that increase the rate of chemical reactions, e.g. to hydrogenate fats, which is the reason for 
the GMP-level in fat (Product Board Animal Feed, PDV). 
Nickel is found in all soil and is emitted from volcanoes. Nickel is also found in meteorites and on the 
ocean floor. Nickel and its compounds have no characteristic odour or taste (ATSDR, 2003). 
2.2 Occurrence 
Nickel is an ubiquitous element in the soil at concentrations <1000 mg/kg, typical concentration range 
in soil is between 4 and 80 mg/kg. In the environment it is primarily found combined with oxygen 
(oxides) and sulphur (sulphides).  
Especially under acidic conditions nickel is available for plant uptake via the roots from the soil. The 
nickel amount in most natural vegetation range from 0.05 to 5 mg/kg dry weight. At concentrations of 
50 mg/kg (dry matter) nickel is expected to be toxic for plants. High concentration factors have been 
found in aquatic plants (bioconcentration factors of up to 20 000).  
In wildlife, nickel is found in many organs and tissues, due to dietary uptake by herbivorous animals 
and their carnivorous predators. However, there is no evidence for the biomagnification of nickel in 
the food chain (ATSDR 2003, WHO working group on nickel, 1991). 
2.3 Toxicological profile (hazard assessment) 
2.3.1 General 
By some authors nickel is considered an essential element for higher animals and humans, although its 
functional importance has not been demonstrated. 
In terms of human health, toxic effects are mainly reported after inhalation of nickel. Via this route, 
nickel carbonyl is the most acutely toxic nickel compound, acute poisoning results in pulmonary 
symptoms are similar to those of a viral pneumonia. The liver, kidneys, adrenal glands, spleen, and 
brain are also affected. Chronic effects such as pulmonary and nasal changes and asthma have been 
reported in nickel refinery and nickel plating workers. Epidemiological studies have demonstrated a 
strong association between lung and nasal cancers and exposure by inhalation to nickel compounds in 
nickel refineries, primarily (in) the early stage of nickel refining. Because of this, nickel compounds 
are classified as carcinogenic to humans (Group 1), metallic nickel is classified as possibly 
carcinogenic to humans (Group 2B; IARC, 1997). 
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Cases of nickel poisoning have also been reported in patients dialysed with nickel-contaminated 
dialysate and in electroplaters who accidentally ingested water contaminated with nickel sulphate and 
nickel chloride. 
Nickel and nickel compounds have a strong sensitising potential on the skin, which is manifested by 
irritation, eczema and allergic contact dermatitis. Oral intake of low doses of nickel may provoke 
allergic dermatitis in sensitised individuals (ATSDR, 2003).  
2.3.2 Combination toxicology 
Although nickel is known to interfere with iron metabolism, no other combination effects of nickel 
have been reported. 
2.3.3 Absorption, distribution, metabolism and excretion (ADME) 
2.3.3.1 Absorption 
Studies with experimental animals and human volunteers have demonstrated a low absorption (less 
than 1%) from food (and feed), but oral absorption from drinking water is higher, reaching 25% 
(nickel sulphate was administered in this case; ATSDR, 2003). The gastrointestinal absorption is 
depending on chelating agents and pH. Iron also seems to affect the gastrointestinal absorption of 
nickel. It can be concluded that the presence of food limits the absorption of nickel and that more 
water-soluble nickel compounds are absorbed better than less soluble ones.  
2.3.3.2 Distribution 
Once taken up, nickel is bound to serum proteins. It is concentrated in kidney, liver, lungs and lymph 
nodes. 
2.3.3.3 Metabolism and excretion 
Elimination half life of absorbed nickel is about 28(± 9) hours (ATSDR, 2003). 
2.4 Human oral exposure 
Because of the scope of this risk assessment, the following paragraphs will focus on human oral 
exposure. 
 
In 2005 the European Food Safety Authority (EFSA) estimated the human intake of nickel from the 
average diet to be about 150 µg/day (2.5 µg/kg body weight/day), but may reach 900 µg/day (15 µg/kg 
body weight/day) or more, when large amounts of food items with high nickel contents are consumed. 
Products with high nickel concentrations are cacao and chocolate, nuts, pod fruit (including soy beans 
and soy products), peanuts, liquorice and whole meal products (Voedingscentrum, 2005). In addition, 
first-run drinking water, which may contain up to 1000 µg/L, and leaching from kitchen utensils into 
food may also contribute to nickel intake. Intakes of 150 and 900 µg/day are about 500 and 90-fold 
lower, respectively, than the lowest dose reported to cause adverse effects in rats. Average intakes from 
food are about one third of the lowest intake reported to aggravate hand eczema in nickel sensitised 
subjects (EFSA, 2005). 
 RIKILT Report 2007.020 18 
2.5 Toxicological reference limits 
National and international organisations reported tolerable daily intake limits (TDI), ranging from 5 to 
50 μg/kg bw/day. EFSA was not able to derive a TDI in de absence of adequate data, but as little as 8 
and 12 µg nickel/kg body weight could provoke hand eczema in nickel-sensitised individuals. See also 
table 1. 
 
World Health Organisation (WHO, 2004): TDI 5 μg/kg bw/day 
This TDI was derived from a NOAEL of 5 mg/kg of body weight per day from a dietary study with 
rats in which altered organ-to-body weight ratios were observed, using an uncertainty factor of 1000 
(100 for inter- and intraspecies variation and an additional factor of 10 to compensate for the lack of 
adequate studies on long-term exposure and reproductive effects, a lack of data on carcinogenicity by 
the oral route and a much higher intestinal absorption when taken on an empty stomach in drinking-
water than when taken together with food). The provisional drinking water quality guideline is 20 μg/L 
(by assuming a 60 kg adult drinking 2 litres of water and allocating 10% of the TDI to drinking water). 
 
WHO (background document drinking-water quality, 2005): TDI 12 μg/kg bw/day 
A critical NOAEL of 2.2 mg nickel/kg bw was based on the results of a two generation study with rats. 
An (standard) uncertainty factor of 100 was applied to the NOAEL. However, this may not be 
sufficiently protective for nickel sensitized individuals. The drinking-water guideline value is derived 
using the LOAEL of 12 μg/kg bw established after provocation of fasted patients with an empty 
stomach. This LOAEL is based on a highly sensitive part of the human population no safety factors 
have to be used a guideline value of 70 µg/L could be determined from this TDI by assuming a 60-kg 
adult drinking 2 litres of water and allocating a conservative 20% of the TDI to drinking-water. 
The LOAEL is based on the total exposure to nickel, in this study, being from drinking-water, and the 
absorption of nickel from drinking water on an empty stomach is 10- to 40-fold higher than the 
absorption from food. Basing the total acceptable intake for oral challenge from studies using 
drinking-water on an empty stomach in fasted patients can, be considered a worst-case scenario.  
Note: this revision of the limit has not been incorporated in the official WHO documents. 
 
Agency for Toxic Substances and Disease Registry (ATSDR, 2003): no limits were derived. 
Intermediate-duration studies suggest that the developing organism may be a sensitive target of nickel 
toxicity. Due to inadequate studies no acute- or intermediate-duration oral MRL has been derived. 
Also the data on chronic toxicity were considered to be inadequate to derive a chronic MRL.  
 
European Food Safety Authority (EFSA, 2005): no limits were derived. 
EFSA was not able to derive an upper level for the intake of nickel from food that is unlikely to pose a 
risk of adverse health effects. Perinatal mortality was reported to be increased in the offspring of 
female rats ingesting nickel salts, even at the lowest administered dose (1.3 mg nickel/kg body 
weight/day). Individuals sensitised to nickel through contact and who have allergic contact dermatitis 
develop effects at lower doses. It is not possible to derive a threshold for provoking dermal reactions 
in nickel-sensitised subjects. Although only dermal exposure to nickel can lead to sensitisation, oral 
doses of nickel have been shown to exacerbate hand eczema in nickel-sensitised individuals. In some 
studies, as little as 8 and 12 µg nickel/kg body weight provoked such reactions. In absence of adequate 
dose-response data for these effects EFSA considered it not possible to establish a TDI. 
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US-Environmental Protection Agency (EPA,1996): RfD 20 μg/kg bw/day for water-soluble nickel 
salts  
This limit is based on decreased body and organ weights in a 2-year feeding study in rats. The NOAEL 
was 5 mg/kg bw/day in addition to the standard uncertainty factor of 100 an additional factor 3 was 
used to account for inadequacies in the reproductive studies. EPA has medium confidence in this RfD, 
based on high mortality in the control group. 
 
National Institute for Public Health and the Environment (RIVM, 2001): TDI 50 μg/kg bw/day 
This TDI is based on the same NOAEL as used by the WHO in 1996 and 2004. The RIVM established 
this TDI in an evaluation in 1991. An uncertainty factor of 100 was used. 
 
Table 1:  Overview of current toxicological safety limits for nickel. 
 Study used  
Organi- 
Sation 
Limit 
type 
Limit 
value 
Exposure Route Species Critical 
dose 
Endpoint Parameter Reference Uncertainty 
factor 
WHO 
(2004) 
TDI 5 
µg/kg 
bw 
2 year Oral 
food 
Rat 5 mg/kg 
bw/day 
NOAEL Decreased 
organ and 
body 
weight 
Ambrose 
et al. 1976 
1000 
WHO 
(2005) 
TDI 12 
µg/kg 
bw 
Single 
dose 
Oral 
drink 
Fasted 
human 
12 
µg/kg 
bw 
LOAEL Eczemato
us 
reaction 
Nielsen et 
al. 1990 
0 
ATSDR -          
EFSA -          
EPA  
(1996) 
RfD 20 
µg/kg 
bw 
Soluble 
Ni salts 
2 year Oral 
food 
Rat 5 mg/kg 
bw/day 
NOAEL Decreased 
organ and 
body 
weight 
Ambrose 
et al. 1976 
300 
RIVM 
(2001) 
TDI 50 
µg/kg 
bw 
2 year Oral 
food 
Rat 5 mg/kg 
bw/day 
NOAEL Decreased 
organ and 
body 
weight 
Ambrose 
et al. 1976 
100 
2.6 Commodity limits 
No regulatory limits have been established for feed materials; nickel is not included in the list of 
undesirable substances in animal feed (directive 2003/32 and amendments). No regulatory limits have 
been established for products (food) of animal origin. In the Netherlands as part of the GMP 
regulations an action level of 20 mg/kg (in fat) and rejection level of 50 mg/kg has been established 
(GMP 14; 17-08-2005). 
2.7 Measurements in feed materials 
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Analyses performed by RIKILT in 2001 – 2004 revealed that concentrations range between 2 and 647 
mg/kg (table 2). These concentrations are higher than those analysed by PDV in feed ingredients. They 
found maximum concentrations, in vegetable oil, ranging between 5 and 10 mg/kg (data not shown). 
 
Table 2:  Nickel concentrations (in mg/kg) in mineral mix and premix for animal feed. Data from 
2001-2004. dl = detection limit of 0,01 mg/kg. Type of animal feed from which the maximum 
concentration originated is specified in the last column. 
Year Maximum Median # samples # > dl % > dl Specification  
2001 45.5 0.28 26 6 23 Additional cattle feed 
2002 518 93 19 19 100 Mineral mix cattle 
2003 647 26.05 48 48 100 Premix 
2004 228 21 44 41 93 
Mineral mix additional cattle 
feed  
 
2.8 Transfer from animal feed to products for human consumption 
From the reviewed literature, no data could be found concerning the transfer of nickel from feed to 
either meat or milk. 
2.9 Considerations for risk assessment 
• Human intake of nickel is mainly originating from consumption of vegetable products, the 
contribution from animal products is marginal.  
 
• It is unclear if nickel is transferred from animal feed to edible animal tissues such as meat, or milk. 
 
• It is unclear to what extent mineral supplements (with its possible nickel content) are used in 
relation to the total amount of animal feed.  
 
• The human daily intake as estimated by EFSA is at the level of the lowest TDI. It is questionable if 
occasional high concentrations of nickel in animal feed will add significantly to this intake.  
2.10 Conclusion 
The additional intake of nickel originating from mineral feed mixes to the human daily intake is 
considered to be marginal. An extended risk assessment using data from the National Control Plan for 
Animal Feed was therefore not performed. 
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3 Mineral oils 
3.1 Introduction 
Food grade mineral oils, or hydrocarbons, are produced as by-products during the refining and 
distillation of crude mineral oils. They may be obtained from crude oil sources of naphthenic (N) or of 
paraffinic (P) origin and by either the conventional acid (oleum)-treatment process (A) or the 
hydrogenation or hydrotreatment process (H).  
Mineral hydrocarbons have been widely used in many different applications which may potentially 
give rise to residues in food. Past or present uses include direct food additives (e.g. as glazing agents), 
constituents of chewing gum base, processing aids (e.g. lubricants), in food packaging materials (e.g. 
wax-coated cartons), in cheese wax, in pesticide formulations, as adjuvant in veterinary medicines, 
and in human medicines (e.g. liquid paraffin laxative). Within Europe, their use as direct food additive 
has diminished and in some countries they are not permitted for food additive use any longer (SCF 
1995). 
3.1.1 Definition 
The characteristics of mineral oils in relation to molecular weights, viscosity and chemical structure 
are poorly defined. The analytical definition of mineral oils is: ‘the sum of all structures between the 
boiling points of n-C10 and n-C40, which are extractable with an apolar solvent and detectable with 
gas chromatography’ (NEN 5733). In short: all straight alkanes with carbon numbers between 10 and 
40. White mineral oils are highly refined mineral oils which are composed of saturated iso-alkane 
(paraffinic) or cyclo-alkane (naphtenic) hydrocarbons. These oils are essentially free of aromatics, 
unsaturated compounds, and impurities such as sulphur, nitrogen, oxygen, halides and metals. Mineral 
oil is also referred to as (mineral) hydrocarbons. 
 
Their viscosity ranges from 10-100 centistokes (cSt1, 10-100 mm2/s). Thus a P100(H) oil refers to a 
paraffinic oil with a viscosity of 100 cSt produced by the hydrogenation process and a N10(A) oil to a 
naphthenic oil with a viscosity of 10 cSt produced by the acid-treatment process (FAO/WHO, 1995).  
There are three main types of products; liquids, semi-liquids and solids, examples of each being 
mineral (white) oils, petroleum jellies and mineral waxes (SCF, 1995). They can be approximately 
classified as follows (EMEA, 1995): 
Low and medium viscosity: C10-C25, viscosity at 100 degrees: 3-8.5 cSt, molecular weights 300-500 
Microcrystalline waxes: C20-C60, viscosity at 100 degrees: 10-30 cSt, molecular weight 300-750+ 
High viscosity: >C30, viscosity at 100 degrees: > 11 cSt, molecular weight >500. 
 
This document focuses on the effects of the aliphatic alkanes with chain lengths between C10 and C40 
which are present in mineral oil, since it was this fraction which was analyzed in animal feed until 
2005 by RIKILT Institute of Food Safety for the National Control Plan for Animal Feed. Where 
relevant, effects of other compounds which may be present in mineral oil are discussed. 
                                                     
1 Viscosity is a measure of the resistance of a fluid to deform under shear stress. Kinematic viscosity 
(Greek symbol: ν) has SI units (m²·s−1). 1 centistokes = 1 mm²/s 
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3.2 Occurrence  
Mineral oil may occur in feed and food as a result from contamination with petroleum products, or 
leaching from package materials into the products. Grob et al. (2001) have conducted a study in 1999 
on the presence of mineral oil in food and feed stuffs. In animal body fat, they found an average 
concentration of 25 mg/kg in the fat phase, with a maximum of 150 mg/kg. In eggs, an average 
concentration of 3 mg/kg with a maximum of 80 mg/kg was found. 
Mineral hydrocarbons, which were supposed to originate from food, have been found in human breast 
milk (Noti et al., 2003). The chain lengths were between C15 and C45, the average molecular weight 
was between C23 and C33, and often more than half were below C25. Concentrations ranged from 25 
to 200 mg/kg fat and were considered as a background concentration common to all women. 
In addition to hydrocarbons originating from mineral oil, the diet will contain other hydrocarbons due 
to biosynthesis of hydrocarbons in terrestrial and marine plants and animal species. Saturated and 
unsaturated n-alkanes with chain lengths of C15, Cl7 and C21 are predominant in marine organisms, 
whilst saturated n-alkanes of chain lengths C27, C29 and C31 are typical of terrestrial plants. 
3.3 Toxicological profile (hazard assessment) 
3.3.1 General 
SCF reviewed unpublished reports in 1995 and found the following effects after oral exposure to 
mineral oils (of which the exact composition is not clear): increased organ weights, especially liver 
and lymph nodes; altered serum enzyme levels; increased monocyte and neutrophil counts; reduced 
red blood cells, haemoglobin, haematocrit, MCHC, MCH; and the accumulation of hydrocarbon 
material in tissues. The main histopathological findings were granulomata in the liver and focal 
collections of vacuolated macrophages (histiocytosis) in the lymph nodes. In animals dosed with 
certain waxes, an inflammatory lesion at the base of the mitral valve in the heart was observed. 
 
Studies in rats and dogs have revealed that ingestion of highly refined white mineral oils induced 
effects on liver and mesenteric lymph nodes, as earlier found by SCF. Effects included increased organ 
weight, microscopic inflammatory changes, and the accumulation of saturated mineral hydrocarbons 
in affected tissues and occurred after intake of a dietary dose of 20 ppm for 90 days. Effects occurred 
only in F344 rats, no statistically significant effects were found in Beagle dogs and Sprague-Dawley 
rats (Smith et al., 1995 and 1996). In addition, Scotter et al. (2003) found comparable effects in F344 
rats after 28-day and 90-day oral exposure to 2% of several types of mineral oils in the diet. They 
identified from chemical analysis from affected tissues, that it was most likely the fraction of straight 
and branched alkanes between C20-C35 that was responsible for the observed effects.  
 
SCF concluded earlier (1995): ‘It is not possible to predict the ultimate consequences for health of the 
reactions observed in some of the animal studies, such as the inflammatory reactions in the liver and 
the mitral valve of the heart. However, we consider that these and some of the other effects noted 
above are undesirable and further consider that there are sufficient parallels between the observations 
of accumulation and effects in animals and man to conclude that there is the potential, depending on 
the intake, for adverse effects on human health.’ 
In addition, they concluded that it is largely the amounts of lower molecular weight, shorter chain-
length substances, which are absorbed and only slowly cleared from the body, that most probably 
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determine the occurrence or absence of toxicity, rather than the presence of very small proportions of 
unusual, highly toxic components. 
 
Hepatic lipid granulomas have been seen in humans exposed to mineral oils through the diet and by 
ingestion of medicinal mineral oils. Doses associated with the effect in humans are not known 
(ATSDR, 1999). A group of pathologists concluded that these granulomas were not the same as those 
observed in the F344 rats and were inconsequential in humans (Carlton et al., 2001). 
3.3.2 Combination toxicology 
From the reviewed literature, no combination effects of the separate compounds in mineral oil could 
be identified. Since mineral oils are complex mixtures of alkanes and other compounds, it is possible 
that interactive effects between the separate ingredients occur. Since mineral oils are usually tested as 
the whole mixture, it is not possible to elucidate the occurrence and/or nature of possible combination 
effects.  
3.3.3 Absorption, distribution, metabolism and excretion (ADME) 
ADME processes are considered and described for the separate alkane fractions and taken mainly from 
the ATSDR toxicological profile on Total Petroleum Hydrocarbons (1999). This profile builds on the 
efforts by the Total Petroleum Hydrocarbon Criteria Working Group (TPHCWG, 1997a and b) and 
Massachusetts Department of Environmental Protection (MADEP) to group chemicals into fractions 
with similar environmental transport characteristics (i.e., transport fractions). Fractions are identified 
by dividing aromatic and aliphatic hydrocarbons by structure and further subdividing on the basis of 
equivalent carbon number index (EC). This index is equivalent to the retention time of the compounds 
on a boiling point GC column (non-polar capillary column), normalized to the n-alkanes. Only 
aliphatic alkane fractions are described hereafter. 
3.3.3.1 Absorption 
EC>8-EC16 and EC>16–EC35 fractions: no studies were found regarding absorption of 
hydrocarbons in these fractions after oral exposure in humans. Studies in rats show that absorption of 
ingested aliphatic hydrocarbons is inversely related to molecular weight, ranging from complete 
absorption at the lower end of the molecular weight range to about 60% for C14 hydrocarbons, 5% for 
C28 hydrocarbons, and essentially no absorption for aliphatic hydrocarbons with >32 carbons 
(ATSDR, 1999). It is commonly assumed that n-alkanes of carbon numbers >29 are not significantly 
absorbed from the gastrointestinal tract (EMEA, 1995). 
3.3.3.2 Distribution 
EC>8 –EC16 fraction: aspiration to the lungs may occur following ingestion of hydrocarbons in this 
fraction (Cavender, 1994, cited by ATSDR, 1999). Following absorption from the gastrointestinal 
tract, smaller molecular weight aliphatic hydrocarbons and/or their metabolites are transported in the 
body via the blood and the lymph system, whereas larger molecular weight aliphatic hydrocarbons 
may be distributed predominately via the lymph system (Review Albro and Fishbein, 1970; Miller et 
al., 1996 cited by ATSDR, 1999). 
EC>16 –EC35 fraction: following absorption, hydrocarbons in this fraction may be expected to 
accumulate to some degree in liver and fatty tissues, as indicated by the observation that, 24 hours 
after administration of an oral dose of tritiated mineral oil to rats, concentrations of tritiated mineral oil 
were about 7-fold greater in fatty tissues and liver than in kidney and brain (ATSDR, 1999). 
Lipogranulomata (clusters of lipoid droplets surrounded by lymphocytes and macrophages) are 
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commonly found in human autopsies, particularly in liver, spleen, and abdominal lymph nodes. These 
structures are associated with dietary exposure to mineral oils and waxes, and are considered a benign 
response without adverse consequences (Miller et al., 1996; Wanless and Geddie, 1985, cited by 
ATSDR, 1999). 
3.3.3.3 Metabolism 
EC>8 –EC16 fraction: hydrocarbons in this fraction are oxidatively metabolized to fatty acids and 
alcohols, apparently mediated by cytochrome P-450 isozymes. Studies regarding the metabolism of 
hydrocarbons in this fraction in humans or animals provide suggestive evidence that metabolism may 
be slow. Studies in rats indicated that aliphatic hydrocarbons in this fraction may be metabolized more 
slowly than aromatic hydrocarbons of equivalent molecular weight (Zahlsen et al., 1992 and Miller et 
al., 1996, cited by ATSDR, 1999). 
EC>16 –EC35 fraction: aliphatic hydrocarbons in this fraction are not expected to undergo extensive 
metabolism in animals or humans. In monkeys, 2 days after intramuscular injection of a mineral oil 
emulsion with a radiolabeled C16 hydrocarbon (n-hexanedecane), substantial portions (30-90%) of 
radioactivity in various tissues existed as unmetabolized n-hexanedecane. The remainder of the 
radioactivity was found as phospholipids, free fatty acids, triglycerides, and sterol esters. No  
radioactivity was found in water-soluble fractions (ATSDR, 1999). 
3.3.3.4 Excretion 
EC>8 –EC16 fraction: results from studies with humans exposed by inhalation to white spirit (a 
mixture of C10-C12 aliphatic hydrocarbons) suggest that hydrocarbons in this fraction are slowly 
eliminated following distribution to fatty tissues (Pedersen et al., 1984, cited by ATSDR, 1999). No 
studies were located regarding the routes of excretion for this fraction of hydrocarbons in humans or 
animals.  
EC>16 –EC35 fraction: hydrocarbons in this fraction may be expected to be eliminated predominately 
in the faeces, based on experiments with rats given oral or intraperitoneal doses of tritiated mineral oil. 
With oral exposure, 90% of administered radioactivity appeared rapidly (within 2 days) in the faeces, 
predominately as unchanged mineral oil; less than 10% of administered radioactivity appeared in the 
urine within 2 days of administration. (ATSDR, 1999). 
3.4 Human oral exposure 
No data regarding the dietary intake of the Dutch population could be found. A study in the USA 
estimated a total dietary intake of mineral hydrocarbons of 0.875 mg/kg bw/day, of which 0.427 mg/kg 
bw/day is of white mineral hydrocarbons (Heimbach et al., 2002). This corresponds with findings in 
the UK, where an average daily intake of 0.47 mg/kg bw/day was calculated for adults (Food 
Chemical Risk Analysis 2001, cited by Noti et al., 2003). For preschool children the corresponding 
value was 0.98 mg/kg bw/day. The Committee on Toxicity of Chemicals in food (COT, 2003) have 
estimated an average daily intake of 0.024 mg/kg bw/day of mineral oils originating from package 
materials in the UK. The separate fractions in this last study could not be identified, but hydrocarbons 
with chain length between C16 and C35 were analysed. 
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3.5 Toxicological reference limits 
Joint FAO/WHO Expert Committee on Food Additives (JECFA, 1995/2002): ADI 0-20 mg/kg bw 
(high viscosity mineral oil: boiling point above 350 ˚C). 
Revised ADI (2002, low- and medium viscosity mineral oil: boiling point above 200 ˚C) 
• 0-10 mg/kg bw for class I: viscosity 8.5-11 mm2/s, carbon number at 5% distillation point not less 
than 25, average molecular weight 480-500, including P70(H) oil; 
• 0-0.01 mg/kg bw (group ADI, temporary) for class II: viscosity 7.0-8.5 mm2/s, carbon number at 
5% distillation point not less than 22, average molecular weight 400-480, including N70(H) and 
N70(A) oils; 
• 0-0.01 mg/kg bw (group ADI, temporary) for class III: viscosity 3.0-7.0 mm2/s, carbon number at 
5% distillation point not less than 17, average molecular weight 300-400, including P15(H), 
N15(H), and N10(A) oils. 
 
Temporary ADIs will be re-evaluated by JECFA in 2006. 
  
TPHCWG (1997), ATSDR (1999), US-EPA (2004) and RIVM (1999) adopted identical limits, 
summarized in table 1. In general, the organisations have used a comparable approach in setting 
toxicological safety limits for total petroleum hydrocarbons (TPH), under which are the mineral oils. 
The methodology selected was termed the indicator/surrogate approach. The indicators referred to are 
the single compounds in petroleum which are known to be carcinogens and which are 
evaluated/regulated individually. If indicator compounds are not present or are below regulatory 
criteria, such as in food-grade mineral oils, hazard assessment for TPH fractions is utilized. For this, 
separate fractions are determined on the basis of structure and equivalent carbon number index (EC, 
see paragraph 3.3.3). A surrogate (single compounds or, preferably, mixtures) is selected which best 
represents the composition of each fraction. The RfDs of the whole fraction have been developed by 
extrapolation of all available toxicity data of the surrogates. Differences in approach by the 
organisations are specified below. 
 
Table 1:  Safety limits for separate alkane fractions of total petroleum hydrocarbons, as adopted by TPHCWG, 
ATSDR, US-EPA and RIVM. US EPA has modified the RfD for the fraction EC8-EC16 in 2004. 
 
 
 
 
 
 
 
TPHCWG (1997): surrogate approach.  
The TPHCWG approach assumes additivity of the surrogate compounds and the hydrocarbon fractions 
in assessing the potential for adverse effects of TPH on health. RfDs are set using the following 
surrogates:  
EC>8-EC16 fraction: using RfD and RfC for dearomatized petroleum streams (white spirit). 
Toxicity data on individual components in the aliphatic >EC8-EC16 fraction are minimal. 
The data used were from studies on jet fuel JP-8 (EC9-EC16) and on de-aromatised 
Aliphatic Total Petroleum 
Hydrocarbon fraction 
Oral RfD/TDI 
mg/kg bw/day 
Uncertainty factor 
applied 
>EC8-EC16 0.1 (US EPA, 2004: 
0.03) 
1000/5000 
>EC16-EC35 2.0 100 
>EC35 20 100 
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petroleum streams (10 studies in total), which, together, cover the entire range of the fraction. 
Although data on n-nonane are available, the data on petroleum streams were preferred since 
these data refer more to mixtures rather than on an individual compound at the low end of 
the fraction. The uncertainty factors (UF) used in these studies varied from 1000, which includes an 
additional factor of 10 to compensate for the use of subchronic studies, to 5000 in one study. The 
additional factor of 5 was applied to compensate for the use of a LOAEL instead of a NOAEL. 
EC>16-EC35 fraction: using RfD for white mineral oils. 
The RfDs for the aliphatic >EC16-EC35 and >EC35 fractions were based on an extensive British 
Industrial Biological Research Association (BIBRA) in Fischer 344 (F/344) rats as reported by Smith 
et al., (1996) in which Fischer rats were exposed to various white mineral oils. The RfD is based on 
the NOAEL for low molecular weight oils for liver granulomas (200 mg/kg bw per day) and a UF of 
100.  
EC>35 fraction: the RfD for the >EC35 fraction (20 mg/kg bw per day) is based on the NOAEL for 
high molecular weight oils for liver granulomas (2000 mg/kg bw per day) and a UF of 100. 
 
ATSDR (1999): adapted surrogate approach of TPHCWG. 
A notable difference between ATSDR and the other groups is that the other groups have focused on 
longer-term exposure scenarios, whereas ATSDR is concerned with the entire spectrum of possible 
exposure periods from acute to chronic. Surrogates were:  
EC>8-EC16 fraction: using a chronic inhalation MRL for JP-7. 
EC>16-EC>35 fraction:  using health effects data for mineral oils, but no MRLs are available 
 
US-EPA (2004): adapted surrogate approach TPHCWG.  
US-EPA adopted the limits as set by the TPHCWG in 1997, but applied several changes in 2004, 
under which for the following aliphatic fraction:  
EC>8-EC16 fraction: the oral reference dose (RfD) for this fraction was based on TPHCWGs 
analysis, plus an additional safety factor of 3 as recommended by US-EPA.  
 
RIVM (1999): identical to TPHCWG.  
All human toxicological TDIs for relevant TPH fractions are based on the criteria set by the 
TPHCWG. 
 
SCF (1995): several group ADIs. 
SCF allocated a full group ADI of 0-20 mg/kg bw for waxes conforming to the following 
specification: 
- Highly refined waxes derived from petroleum based or synthetic hydrocarbon feed stocks, with 
Viscosity not less than 11 cSt at 100°C; 
- Carbon number not less than 25 at the 5% boiling point; 
- Average molecular weight not less than 500; 
Any further data on these waxes was not required. 
 
SCF allocated a temporary group ADI of 0-4 mg/kg bw for oils conforming to the following 
specification: 
- White paraffinic mineral oils derived from petroleum based hydrocarbon feed stocks, with 
Viscosity not less than 8.5 cSt at 100°C; 
- Carbon number not less than 25 at the 5% boiling point; 
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- Average molecular weight not less than 480. 
A chronic toxicity/carcinogenicity study of 2 years duration on P70(H) oil was required, which 
includes a reversibility phase in which a satellite group dosed for 1 year is left untreated for a further 
year, to be submitted within 4 years. 
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3.6 Commodity limits 
PDV (2001): There are no EU- or national commodity limits for mineral oil in animal feed. PDV 
recommends action- and rejection limits for crude oils and fats in the animal feed sector (see table 2). 
 
Table 2:  Action/rejection limits for mineral oil in animal feed as proposed by PDV (2001) 
Group compounds Action/rejection limit (%m/m) 
Animal fat (excl. fish oil) 0.04 (400 mg/kg) 
Vegetable oil (excl. sunflower oil) 0.04 (400 mg/kg) 
Vegetable fatty acids (incl. mixtures of 
fatty acids) 
0.3 (3000 mg/kg) 
Crude fish oil 0.3 (3000 mg/kg) 
Sunflower oil and fatty acids 0.1 (1000 mg/kg) 
3.7 Measurements in feed materials 
As Grob et al. (2001) stated: it must be kept in mind that results on hydrocarbons do not refer to the 
total of the contamination. Furthermore, this concentration cannot be interpreted as an indicator of 
toxicity. The hydrocarbons are probably the least toxic waste components. There is no hint whether 
they are accompanied by PCBs or other highly toxic components, nor does a high concentration of 
mineral oil material necessarily go along with a high concentration of toxic material. 
 
Analyses of mineral oil in animal feed have been performed by RIKILT from 2000 until 2005. The 
highest concentrations were found in 2000 in linol fat, with a concentration of 1.02% (m/m). The 
following years, concentrations were not higher than 0.14%, mostly in palm oil fatty acids. This last 
value is below the proposed rejection limit of 0.3 of PDV. See also table 3.  
 
Table 3:  Mineral oil concentrations in % (m/m) in fats and oils for use in animal feed. Data from 2000-2004. dl 
= detection limit of 0,04%. Fat type from which the maximum concentration originated is specified in the last 
column. 
Year Maximum Median # samples # samples >dl Specification fat 
2000 1.02 0.18 59 17 (28%) Linol fat 
2001 0.14 0 97 4 (4,1%) Bird fat 
2002 0.05 0.05 50 1 (0,5%) Palm oil fatty acid 
2003 0.1 0.1 19 3 (16%) Palm oil fatty acid 
2004 0.14 0.1 16 3 (19%) Palm oil fatty acid 
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3.8 Transfer from animal feed to products for human consumption 
Although hydrocarbons have been found in goats milk (Cerbulis et al., 1985), it is unclear to what 
extent petroleum hydrocarbons are transferred from feed to milk or meat. Uptake of mineral oil by 
cows from feed can be concluded from the following studies by Coppock et al. (2001, 2002), who 
found temporary accumulation of n-alkanes (c10-c19) in the adipose tissue of cows exposed to crude 
oil and diesel in the feed. For the hydrocarbons with higher chain length (>C30) it is known that they, 
like in humans, are not absorbed in ruminants and have a laxative effect. Paraffin is also medicinally 
used for this purpose. Crude oil has been seen as having this effect in cattle (Poppenga, 2000). 
 
Khan et al. (2005) have identified that oral exposure of cows to the crude oil and diesel as used in the 
studies by Coppock et al. (2001, 2002) resulted in a decrease in biochemical reactions of 
polymorphonuclear leukocytes (phagocytosis pathway), thus affecting immunity of the ruminants, 
even at concentrations as low as 0.005% (v/m) crude oil and 0.0025% (v/m) diesel. Earlier, they had 
discovered induction of P450 enzymes in rats after oral exposure to the same crude oil as used in the 
study in cattle. In this study, they also had found similar accumulation of n-alkanes (C10-C19) in the 
adipose tissue from the rats (Khan et al., 2002). It is not clear which substances in the dosed oils are 
responsible for the effects seen in rats and cattle, induction of the P450 enzymes indicates that it might 
be Ah-receptor mediated, suggesting that compounds like PAHs could be responsible. However, it has 
been shown that alkanes from oil and diesel are taken up and distributed in the cow, and could thus be 
present in milk and meat meant for human consumption.  
3.8.1 Risk for animal health 
Assuming that approximately 1.4% fat is used in the production of feed for cows (Kemme and Van 
Raamsdonk, 2004), combined with the measured concentration of 0.14 % in palm oil fatty acids, a 
concentration of 0.002% could be present in cow feed. This value of isolated alkanes is similar to the 
0.0025% diesel concentration in animal feed which induced immunotoxic effects in cattle. It may be 
expected that the total concentration of the product from which the measured alkanes originated is 
higher.  
Another matter of interest is that the concentrations which induce these effects on immune response in 
cattle are below those proposed by PDV. 
3.9 Considerations for risk assessment 
Alkanes or hydrocarbons below C30 are taken up by mammals and subsequently induce effects. In 
rats, effects are microgranulomas in liver and mesenteric lymph nodes, but only in F344 rats and not in 
other rats or in dogs. In humans, comparable accumulations of alkanes in liver and lymph nodes after 
ingestion of mineral oil have been found.  
The relevance of these effects for humans is not clear. There is no information on the extrapolation 
from this specific strain of rats to humans. SCF concluded that these effects are undesired and are 
related to the alkanes rather than occasional very toxic compounds in the mineral oil. The opinon of a 
panel of pathologists that the observed effects in rats and humans are of non-adverse nature has not led 
to a review of SCF’s opinion. Finally, several organisations have derived safety limits based on the 
effects in F344 rats. 
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A different effect seen in animals after oral exposure to mineral hydrocarbons is the suppression of 
immune response. In cows, biochemical reactions in the phagocytosis pathway of white blood cells 
were suppressed after oral exposure to crude oil and diesel. Although accumulations of alkanes were 
found in the fat tissue, it is not known which compounds in the oil were responsible for the effects. 
Exposure of rats to the same crude oil resulted in induction of P450 enzymes, indicating that activation 
of the Ah-receptor pathway may be involved. The presence of alkanes in the animal fat may indicate 
that they could also be transferred to milk, thus additionally exposing humans. 
 
In humans, mineral hydrocarbons were detected in breast milk. The hydrocarbons were supposed to 
originate from food, and thus absorbed by humans. Mineral oils in the human diet can originate from 
contamination of animal feed or food (oils or lubricants which can leak from machinery into the 
feed/food during production) or application as food additive. Another route of exposure is from 
package materials, from which the hydrocarbons migrate into the food.  
 
The amount of mineral oil in feed and food is usually measured by GC analysis of the C10-C40 
hydrocarbon fraction in materials. Natural alkanes cannot be distinguished in this analysis (personal 
comment Wim Traag, RIKILT Institute of Food Safety). Additional to the effects induced by alkanes, 
it is expected that the overall toxicity of mineral oil is more dependent on the presence of other 
compounds, such as toluene, PCBs or PAHs. It has not been possible to correlate the results of alkane 
analysis to the presence of these latter compounds. The toxicological relevance of the hydrocarbon 
analyses or its indicator function for total contamination remains thus unclear. Considering all this, a 
full risk assessment using data from the National Control Plan for Animal Feed was not performed. 
3.10 Conclusions and recommendations 
• Oral exposure to alkanes induces microgranuloma in F344 rats, not in other rats or dogs. Similar 
phenomenen have been observed in humans after oral exposure to mineral oil. There is no 
consensus to whether the effects in rats and humans are of an adverse nature. 
 
• The feasability of the TDIs for mineral hydrocarbons is questionable. Human total hydrocarbon 
intake from food-use applications exclusively already exceeds the low TDI for fraction EC8-16. 
The contribution of alkanes from this fraction to the total hydrocarbon intake is not clear. Analysis 
of hydrocarbons present in food or feed is usually not specified for the separate fractions, which is 
severely hampering the correlation of the exposure to the TDI. Detailed analysis of hydrocarbons 
(specified into separate fractions) in food and feed is recommended. 
 
• There is very limited information on the transfer of separate fractions of hydrocarbons from feed 
to animal products. For a more detailed risk assessment, further research on this carry-over is 
needed. 
 
• Alkane analysis can only be used as an indicator for incidents with mineral oil in animal feed, and 
not as indicator for the presence of highly toxic compounds. 
 
• Alkane analysis can only provide a total alkane concentration. Natural alkanes cannot be 
distinguished from alkanes originating from mineral oil. 
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• Oral exposure of crude mineral oil in feed induces effects on the biochemical immune response in 
cows. Extrapolating results from alkane analysis in feed ingredients, the concentration in animal 
feed could be similar to the effect concentration. Proposed PDV levels exceed the effect 
concentration. The protection of animal health could be a factor in the decision on monitoring of 
mineral oil in animal feed. 
 
• Considering the above mentioned uncertainties in interpreting the analytical results, inclusion of 
mineral oils in the National Control Plan for Animal Feed is not recommended.  
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4 Poly Aromatic Hydrocarbons 
This chapter has previously been published as a report from RIKILT – Institute of Food Safety, 
number 2006.001. 
4.1 Introduction 
In 2003 it was recognized that data on the carry-over of Poly Aromatic Hydrocarbons (PAHs) from 
animal feed to milk were very limited. In order to provide new data an animal study was initiated to 
study the carry-over from animal feed to milk. Cows were fed diets with a level of contamination that 
was thought to be representative of the situation in practices. However, an evaluation of the results 
from the National Control Plan for Animal Feed was not performed in this study. 
The current report is an extension of the above mentioned study. An initial risk-assessment of the 
PAHs (shown in table 1) is reported including an exposure assessment of food producing animals. In 
addition, the contribution of the consumption of animal products to the PAH burden of consumers are 
briefly mentioned.  
 
Table 1:  Details of PAHs evaluated in this document. BaPEF = factors expressing relative carcinogenic potency 
as compared to Benzo(a)Pyrene (taken from Hoogenboom et al., 2003). See also paragraph 3. 
Name Classification # Rings CAS nr BaPEF 
Acenaphthylene 
Acenaphthene 
Fenanthrene 
Fluoranthene 
Pyrene 
Benzo[a]anthracene  
Chrysene 
Benzo[b]fluoranthene 
Benzo[k]fluoranthene 
Benzo[a]pyrene 
Indeno[1,2,3-c,d]pyrene 
Dibenzo[a,h]anthracene 
Low molecular 
Low molecular 
Low molecular 
Low molecular 
High molecular 
High molecular 
High molecular 
High molecular 
High molecular 
High molecular 
High molecular 
High molecular 
2 
2 
3 
3/4 
4 
4 
4 
4/5 
4/5 
5 
5/6 
5 
208-96-8 
83-32-9 
85-01-8 
206-44-0 
129-00-0 
56-55-3 
218-01-9 
205-99-2 
207-08-9 
50-32-8 
193-39-5 
53-70-3 
0.01 
0.001 
0.001 
0.01 
0.001 
0.1 
0.01 
0.1 
0.1 
1 
0.1 
1 
 
Definition 
PAHs are a group of chemicals composed of two or more fused aromatic rings made up of carbon and 
hydrogen. At ambient room temperatures PAHs are solids. Generally, they have high melting and 
boiling points, low vapour pressure, and very low water solubility. PAHs are very lipophilic, and 
chemically rather inert. They are used as intermediates in the production of plastics and plasticizers, 
pigments and dyes, and pesticides. The largest emissions of PAHs into the environment result from 
incomplete combustion of organic materials during industrial processes and other human activities.  
Many of the PAHs are considered genotoxic carcinogens, depending on their molecular structure. 
PAHs are usually distinguished in low molecular weight PAHs (2 or 3 aromatic hydrocarbon rings) 
and high molecular weight PAHs (4 aromatic hydrocarbon rings and more), from which the latter are 
less acutely toxic but more carcinogenic and teratogenic (Baars et al., 2001). Some organisations (like 
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United States Environmental Protection Agency US-EPA) consider PAHs with 4 rings also to be low-
molecular, in this document however, the first definition will be used. 
For the general population, the major routes of exposure to PAHs are from food and ambient and 
indoor air. PAHs in food may originate from air, soil or water by environmental contamination, or by 
PAH formation during processing and cooking. This processing of food (such as drying and smoking) 
and cooking of foods at high temperatures (grilling, roasting, frying) are major sources of PAH 
contamination (Guillén et al., 1997; Phillips, 1999). Cigarette smoking increases PAH exposure 
significantly (World Health Organisation WHO, 2002). 
4.2 Occurrence  
Kan et al. (2003) reviewed the occurrence of PAHs in animal products. In France, PAHs have been 
found in milk at total concentrations of 37 and 27 ng/g fat (Grova et al., 2000 and 2001). 
Concentrations were not significantly different between milk from cows in a highly industrial area and 
a relatively ‘clean’ rural area. In another study, concentrations up to 4 µg/kg and 125 µg/kg were found 
in respectively locally produced and imported cheese in Finland. Concentrations up to 70 µg/kg were 
found in meat. In uncooked foods, the average background values are usually in the range of 0.01-1 
µg/kg (Scientific Committee on Food SCF, 2002). 
4.3 Toxicological profile  
Evidence that mixtures of PAHs are carcinogenic to humans is primarily derived from occupational 
studies of workers following inhalation and dermal exposure. No data are available for humans 
following the oral (food) route of exposure. There are few data from animal studies on the oral toxicity 
of PAHs other than Benzo(a)Pyrene (BaP), and most studies focus on the carcinogenic properties. For 
BaP there are two oral carcinogenicity studies, one in mice and one in rats. In available studies animals 
were mostly exposed to contaminated drinking-water. The acute oral toxicity of PAHs ranges from 
very to moderately toxic (50 to 1000s mg/kg bw) in rats. When applied on the skin, many PAHs are 
cancer-causing, producing tumours in epithelial tissues in "practically all animal species tested" 
(Agency for Toxic Substances and Disease Registry ATSDR, 1995).  
Carcinogenic PAHs in general show clear positive effects in genotoxicity tests and from DNA-adducts 
in exposed animals. Many PAHs, and in particular their hydroxy metabolites, may induce 
(anti)estrogenic effects. Gozgit et al. (2004) found that a metabolite of BaP was capable of inducing 
estrogenic response genes in vitro in human breast cancer cells. In addition, Van de Wiele et al. (2005) 
discovered that colon microbiota transformated PAHs to metabolites, which induced a estrogenic 
response in a yeast estrogen bioassay. For their study, they used a gastro-intestinal simulator. Whether 
the observed effect occurs in vivo, when several enzymes could interfere with the transformation, is 
yet unclear. 
The immunotoxicity of PAH has been known for a number of years. The immunotoxic effect most 
often reported following exposure to PAH is immunosuppression. It should be noted that most studies 
on the immunotoxicity of PAH have used parenteral administration and that most of the available data 
consider only a few selected substances, benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene being 
most widely used (SCF, 2002). 
PAHs bind to the Aryl-hydrocarbon (Ah) receptor, and could thus be capable of inducing dioxin-like 
effects. There are indications that this mechanism plays an important role in the carcinogenicity of 
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PAHs. Other effects in terrestrial organisms include adverse effects on reproduction, development, and 
immunity (SCF, 2002; ATSDR, 1995).  
 
Benzo(a)Pyrene (BaP) is the most potent compound of the PAHs based on carcinogenicity. Relative 
potencies of carcinogenic PAHs to BaP have been determined by comparison of data which come 
primarily from dermal studies. The order of potencies is consistent, and this scheme therefore can 
provide an indicator of PAH potency relative to BaP, expressed as BaPEQ (BaP equivalents). 
Controversy exists concerning the use of this expression of relative carcinogenicity, since not all PAHs 
induce cancer via identical mechanisms. Also, data on oral studies are scarce and absorption and 
metabolism may play an important role in the effects. SCF has decided that benzo(a)pyrene is a good 
indicator of the PAH content. Based on studies with coal tar, they conclude that multiplication of the 
BaP-content by a factor of 10 will give a good indicaton of the total potency of the mixture. However, 
this refers only to the high-molecular PAHs (SCF, 2002). For reasons discussed in paragraph 5, the 
results in this initial risk assessment will be evaluated in weight only*. 
 
Please note that this assessment only deals with oral exposure of consumers via the route of animal 
products. 
4.4 Combination toxicology 
In carcinogenic mechanisms, PAH mixtures have been shown to induce differential effects in covalent 
DNA binding when applied to mouse skin in different combinations. Effects varied from synergism to 
antagonism, depending on the applied combination (Hughes and Philips, 1990). Like dioxins, PAHs 
can have combination effects like synergism or antagonism when binding to the ArylHydrocarbon 
receptor and induce dioxin-like effects (Chaloupka et al., 1993). After oral exposure, BaP has shown to 
enhance the immune response to the food allergen ovalbumine in mice (Kadkhoda et al., 2004). 
4.5 Absorption, Distribution, Metabolism and Excretion (ADME): 
Absorption of PAHs from the gastro-intestinal tract appears to vary per animal species. BaP absorption 
reached 89-99% after oral (food) exposure of rats (Rabache et al., cited by Kan et al, 2003). Another 
study in rats showed that first a direct absorption occurs 1-2 hours after feeding. After 3-4- hours a 
second increase in serum concentration occurs due to entero-hepatic circulation (Van Schooten et al. 
1997, cited by Kan, 2005). In contrast, a study from Grova et al. (2002) showed that activity from 
radio-labeled BaP was not traced in blood and milk from orally exposed lactating goats.  Hoogenboom 
et al. (2005) concluded from this study that the heavier PAHs are apparently not absorbed from the 
gastro-intestinal tract (and transferred to milk). Since the rat seems more relevant as a model for 
human uptake, it is considered that in humans PAHs may be readily absorbed from the gastro-
intestinal tract. 
 
The rate of distribution of PAHs can be influenced by the presence of other (fatty) compounds that 
may enter the body at the same time with PAHs. PAHs can enter all the tissues of the body that contain 
                                                     
* Recently the discussion on expression of concentrations of PAHs was continued during a meeting of an expert group 
organised by JRC and EFSA. In addition EFSA announced to develop a database that should contain PAH concentrations in 
food commodities (http://www.efsa.eu.int/science/data_collection/pah/1168_en.html ) 
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fat. They tend to be stored mostly in the kidneys, liver, and fat. Smaller amounts are stored in the 
spleen, adrenal glands, and ovaries (ATSDR, 1995). 
 
Detoxification of PAHs is complicated, and is performed by various enzymatic and nonenzymatic 
reactions. PAHs are converted to arene oxide intermediates followed by formation of derivatives of 
trans-dihydrodiols, phenols, and quinones. These intermediate products are known to be toxic, 
carcinogenic, and/or mutagenic. Results from animal studies show that PAHs do not tend to be stored 
in the body for a long time. Most PAHs that enter the body leave within a few days, primarily via feces 
and urine (ATSDR, 1995). 
4.6 Toxicological reference limits 
Based on existing NOAELs for non-carcinogenic effects of PAHs, the US EPA (IRIS, 2002) has 
derived Reference Doses (RfDs) for chronic oral exposure for acenaphthene, anthracene, fluoranthene, 
fluorene, naphthalene and pyrene. Large safety factors were used by the US EPA because of the 
limited databases available and the use of subchronic studies and not chronic studies for the derivation. 
According to EPA it is the carcinogenic and genotoxic potential of PAH that is critical for the risk 
assessment, because exposure to PAH in food is almost exclusively to a mixture of PAH which 
includes genotoxic and carcinogenic PAH. The non-carcinogenic effects of individual components are 
generally considered not to be relevant for the assessment of the risk of such mixtures. However, there 
are more and more data that indicate that in the case of milk production, only the low-molecular (non-
carcinogenic) PAHs are transferred from feed to the milk in their original form (Lutz et al., 2005, 
Grova et al., 2002). Therefore, a risk assessment using TDIs based on non-carcinogenic effects could 
be useful. An orientation on this matter using data from the National Control Plan for Animal Feed has 
been performed and is described in paragraph 6. 
 
Based on carcinogenic potential, the following organisations have derived reference limits: 
 
World Health Organisation (WHO, 1998, 2003): drinking water guideline 0.07 μg/litre. 
The 1993 Guidelines (retained in 1998) concluded that there were insufficient data available to derive 
drinking-water guidelines for PAHs other than BaP. The guideline value for BaP was based on a study 
in CFW mice which were fed BaP in the diet. In the mice an increase of stomach tumours associated 
with an increase in the ingested concentration of BaP was observed. The tumour incidence data have 
been extrapolated using the two-stage birth - death mutation model. The estimate of the upper bound 
on the low-dose risk was 0.46 (mg/kg of body weight per day). The derived guideline value for BaP, 
corresponding to an upper-bound excess lifetime cancer risk of 10-6, was calculated to be 0.07 μg/litre. 
Although a health-based value for fluoranthene was calculated in the addendum, it was significantly 
above the concentrations found in drinking-water, and it was concluded that, under usual conditions, 
the presence of fluoranthene in drinking-water does not represent a hazard to human health; thus, the 
establishment of a guideline value for fluoranthene was not deemed necessary.  
 
Agency for Toxic Substances and Disease Registry (ATSDR): no reference limits derived. 
ATSDR did not derive chronic oral minimal risk levels (MRLs) for polycyclic aromatic hydrocarbons 
(PAHs) because there are no adequate human or animal dose-response data available that identify 
threshold levels for appropriate non-cancer health effects.  
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US - Environmental Protection Agency (EPA, 2002): virtually safe dose 0.14 ng BaP/kg bw/day. 
Using the oral slope factor of 7.3 per mg benzo[a]pyrene/kg bw/day for the carcinogenic risk from 
benzo[a]pyrene exposure as developed by US-EPA (Integrated Risk Information System IRIS, 2002) 
an oral “virtually safe dose” for benzo[a]pyrene of 0.14 ng /kg bw/day was calculated for a cancer risk 
level of 1x10-6 via linear extrapolation. 
 
Scientific Committee on Food (SCF, 2002): no reference limits derived. 
The SCF have concluded in 2002 that since a number of PAH have been demonstrated to be genotoxic 
and carcinogenic, the existence of a threshold could not be assumed and therefore, the Committee did 
not establish a safe exposure limit. It was recommended that exposures to PAH should be as low as 
reasonably achievable. EFSA has scheduled a review of PAH data for April 1st 2007. 
 
Rijksinstituut voor Volksgezondheid en Milieu (RIVM, 2001): VSD 0.5 ng PAHs /kg bw/day. 
Based on a 3-year oral study in rats, RIVM derived a limit of 5 ng BaP/kg bw/day (from a LOEL of 10 
mg/kg bw/day for tumour incidence) which would correspond with a cancer risk level of 1x10-6 
(Kroese et al., 2001). On the basis of the available data on occurrence and carcinogenic potency of 
PAHs in the Dutch diet, the authors suggested to apply a correction-factor of 10 for conversion to a 
VSD for all dietary PAHs, resulting in a VSD of 0.5 ng B[a]P/kg bodyweight per day, taking B[a]P as 
PAH indicator. 
 
Based on non-carcinogenic potential, the following organisations have derived reference limits: 
 
US-EPA (1993, 1994): several RfDs. 
For acenaphtene, US-EPA (1994) derived a RfD of 0.06 µg/kg bw/d based on a subchronic NOEL of 
175 mg/kg bw/d for hepatotoxicity in mice. 
For fluoranthene, US-EPA (1993) derived a RfD of 0.04 µg/kg bw/d on a subchronic NOEL of 125 
mg/kg bw/d for nephropathy, increased liver weights, hematological alterations, and clinical effects in 
mice. 
For pyrene, US-EPA (1993) derived a RfD of 0.03 µg/kg bw/d based on a subchronic NOEL of 75 
mg/kg bw/d for kidney effects (renal tubular pathology, decreased kidney weights) in mice. 
No RfDs were derived for other PAHs relevant to this document. 
 
RIVM (2001): TDI of 40 µg/kg bw/d for phenanthrene. 
RIVM derived a chronic TDI of 40 µg/kg bw/d for phenanthrene. Although they considered this 
compound to be carcinogenic, its carcinogenic potency was considered to be extremely low and 
therefore the TDI for non-carcinogenic PAHs was applied. This TDI was derived from the evaluation 
of Total Petroleum Hydrocarbons, where an overall TDI of 40 µg/kg bw/d was set for non-
carcinogenic aromatic compounds with equivalent carbon index (EC, this index is equivalent to the 
retention time of the compounds on a boiling point GC column (non-polar capillary column), 
normalized to the n-alkanes) of >9 to 16, and 30 µg/kg bw/d for those with equivalent carbon numbers 
of >16 to 35 (see document on Total Petroleum Hydrocarbons for details). 
4.7 Human oral exposure 
In a study of De Vos et al. (1990, cited by SCF, 2002) a worst case scenario was used for calculation, 
resulting in a daily exposure of 420 ng/kg bw BaP for Dutch consumers. In this study, an average 
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intake of 4.8 ng/kg bw/day BaP and 284 ng/kg bw/day total PAHs was calculated (cited by COT, 
2002). The major contributors to the daily BaP intake were oils and fats (47%), cereals (36%) followed 
by sugar and sweets (14%). These results were in line with other studies of the UK diet (Dennis et al., 
1983, cited by SCF, 2002). The relatively high contribution of oils and fats was, at least partly, 
attributed to the well-known elevated PAH concentrations present in vegetable oils. However, 
measurements for the study of De Vos et al. were performed from 1982-1986, thus 20 years ago. The 
more recent total diet study in the UK (COT, 2002) showed that the contribution from oils and fats to 
the total PAHs intake was far less than in previous studies.However, the contribution from milk and 
dairy products had increased to 12% and 9% respectively. In addition, partitioning of PAHs in the total 
PAH uptake was changed. Although the composition of the diet samples were different from the earlier 
studies, the increase in milk contribution is relevant to the risk assessment performed here. The 
contribution from other animal products is far less, and will therefore not be included in the initial risk 
assessment. The focus of this document will be on human oral exposure via milk and dairy products. 
4.8 Measurements in feed materials 
To evaluate the effect of the method of expression of PAH concentrations on the interpretation of 
results, data on PAHs in dried grass were evaluated based both on benzo(a)pyrene equivalents 
(BaPEQs) and based on weight. Analysis in the Netherlands of artificially dried grass by RIKILT 
showed a range from 0.6-18.9 ng BaPEQ/gr dried product in 2000 and 2001. In 2002/2003 this range 
varied from 0-7.3 ng BaPEQ/g in dried grass and 0.8-180 ng BaPEQ/g in grass pellets. As could be 
expected, the contribution of high-molecular PAHs to the total BaPEQs was much higher than the low-
molecular PAHs, as the BaPEQs are based on carcinogenic properties. In weight, the contribution of 
low-molecular and high-molecular PAHs is equal on average, in dried grass the contribution from low-
molecular PAHs seems to be slightly higher (average 58.3 and 41.7%).  
The previous indicates that expression of PAH concentration in BaPEQs may result in a 
underestimation of the total concentration of PAHs. To obtain a clear image of the distribution of 
PAHs in feed ingredients measured for the National Control Plan for Animal Feed, the data will thus 
be expressed in weight only. 
 
Data from the National Control Plan for Animal Feed have been processed and results are shown in 
table 2. Matrices were categorised and maximum and median concentrations per category were 
determined. Details on this calculation can be found in ANNEX I. 
 
Table 2:  Maximum concentrations of PAHs  in feed ingredient categories as measured in the National Control 
Plan for Animal Feed from 2000-2004. Concentrations in µg/kg. ACE=Acenaphthene, ACY=Acenaphthylene, 
BAA=Benz[a]anthracene, BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, 
CHR=Chrysene, DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene.  
Category ACE ACY BAA BAP BBF BKF CHR DBA PHE FLU IDP PYR 
1 Flakes 34.78 2.00 3.17 2.00 1.74 0.38 4.79 0.14 76.16 15.83 1.10 31.87 
2 Oils/fats 9.20 6.50 7.60 9.80 9.50 7.20 9.00 6.30 9.00 9.60 9.10 9.50 
3 Citrus 5.30 2.50 7.60 9.60 6.50 2.40 9.20 0.10 0.10 0.10 6.90 0.10 
4 Roughage (dried) 13.36 12.94 14.30 9.80 10.18 8.80 15.07 8.40 80.80 157.40 8.50 98.20 
4a Roughage (silage) 1.20 1.80 8.20 7.90 9.10 4.30 0.72 1.20 3.90 2.70 5.40 1.90 
5 Other 1.10 0.66 6.00 7.30 6.00 3.10 5.30 0.88 5.10 4.60 5.00 2.90 
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4.9 Commodity limits 
There are only few limits for PAHs in feed and feed ingredients. As a result of the mixing of diesel oil 
with palm oil, the Product Board Animal Feed set a limit of 50 µg BaPEQ/kg fat for vegetable oil and 
oil derived waste products. In addition an action limit of 15 µg BaPEQ/kg fat was established (PDV, 
2001). 
4.10 Transfer from animal feed to products for human consumption 
Based on the often high levels in dried grass, Kan et al. (2003) performed an exploring study on the 
transfer of PAHs from feed to milk in lactating cows. They reported very low transfer of PAHs to milk. 
Acenaphtene, phenanthrene, fluoranthene, pyrene and chrysene were detected to some extent in the 
milk, but the more heavy PAHs were not present at levels above the detection limit of 0.1 ng/g fat. 
Analysis did not include metabolites. Grova et al. (2002) detected traces of low-molecular fluorene-, 
phenantrene- and pyrene related radioactivity in milk after oral exposure of goats to several 
radiolabeled PAHs. BaP-related activity was hardly detected in milk (0.2%) and mainly excreted in the 
feces (88%). This does not exclude entero-hepatic cycling and thus a much larger initial absorption of 
BaP. A recent study from Cavret and Feidt (2005, 2005a) indicated the importance of metabolism in 
the fate of PAHs and transfer to milk. In another study, Lutz et al. (2005) did not detect the parent 
compounds, but found the hydroxy-metabolites from fluorene, phenantrene and pyrene in the milk 
from cows which were chronically exposed to PAHs through oral soil intake.  
Metabolites are usually not included in the ‘classical’ monitoring schemes of PAHs. It can be 
concluded from recent studies that it is likely that low(er)-molecular PAHs with less than 5 rings are 
transferred to milk as native compound after oral exposure. The study of Kan et al. (2003) confirms 
this assumption. In addition, evidence from literature suggests that even more PAHs are transferred as 
metabolites (Lutz et al., 2005), possibly including those of the high-molecular PAHs. 
4.11 Initial risk assessment 
As seen in previous paragraphs, PAHs can transfer from contaminated feed to milk, as native 
compounds or as metabolites. By consuming this milk, humans may be exposed to the PAHs 
originating from the feed. To evaluate the possible risk of exposure to these PAHs, an initial risk 
assessment was performed. For this, various worst-case exposure calculations were performed to 
estimate the human exposure to PAH via the consumption of milk. Available data from the National 
Control Plan for Animal Feed on PAH concentrations in animal feed was used. On some matrices no 
or very limited data was available from the National Control Plan, for instance for fresh grass. On this 
last matrix, a brief literature review was undertaken resulting in data from a few studies. 
4.11.1 Description of scenario’s 
Using the maximum and median concentrations measured in the defined categories of feed 
ingredients, concentrations in compound feed were calculated. PAH concentrations in milk resulting 
from feed intake by cows were calculated using transfer rates derived from the study of Kan et al. 
(2003) and from the studies of Lutz et al. (2005) and Grova et al. (2002). To calculate possible 
concentrations in cow’s milk, the procedures as introduced by Van Raamsdonk et al. (2004) were used. 
Human intake was then calculated and compared to the known reference values using standard 
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methods of the European Medicines Agency (EMEA, 1995), RIVM and RIKILT (RIVM/RIKILT 
FrontOffice Voedselveilgheid, 2005). For details on the method of calculation, see ANNEX I. 
 
The winter and summer scenarios were based on the availability of feed during the year. In winter, no 
fresh grass is available, so only silage and dried pellets are used as roughage feed. In summer, the 
main component in roughage is fresh grass. For comparison with the experimental data obtained by 
Kan et al. 2003, the feeding regime used in this study was also used as scenario. Feeding regimes in 
the scenarios are described in the next paragraphs. Details on amounts of feed can be found in table A6 
in ANNEX I. 
4.11.2 Scenario Winter 
The winter feeding regime as used by Van Raamsdonk et al. (2006, in preparation) was used. Three 
winter scenarios were designed because of the relative high concentrations of PAHs in dried grass 
pellets. It is assumed that the PAHs are introduced by the drying process, although this remains to be 
confirmed. Theoretically, farmers in the vicinity of drying facilities will use more dried materials than 
farmers further away, because of the costs of transportation. In three scenario’s, the percentage of 
silage in the winter feeding regime is replaced in varying proportions by grass pellets to simulate this 
variety in feed sources. The consequence of this varying use is calculated accordingly. Concentrations 
in corn silage were assumed to be equal to grass silage (note: only two samples of grass silage were 
present in database). 
 
Winter 1 (W1): Normal percentages of concentrate were used. Roughage consisted completely of grass 
and corn silage. 
 
Winter 2 (W2): Normal percentages of concentrate were used. Roughage consisted half of grass and 
corn silage and half of grass pellets. 
 
Winter 3 (W3): Normal percentages of concentrate were used. Roughage consisted completely of grass 
pellets. 
4.11.3 Scenario Summer 
The summer feeding regime as used by Van Raamsdonk et al. (2006, in preparation) was used. Two 
summer scenarios were designed because of the lack of data from fresh grass samples in the National 
Control Plan for Animal Feed. The scenarios differ in the use of PAH concentrations in fresh grass, for 
one scenario no data are used (current situation), and for one scenario data is taken from literature. 
This way the consequence of the current monitoring strategy for risk assessment results could be 
evaluated. 
 
Summer 1 (S1): Normal percentages for concentrate and silage were used. No grass pellets were 
included in the regime. PAH content of fresh grass was considered to be 0 mg/kg. 
 
Summer 2 (S2): Normal percentages for concentrate and silage were used. No grass pellets were 
included in the regime. PAH concentrations in fresh grass were taken from Crépineau-Ducoulombier 
et al. (2004, control site 2), where concentrations lower than detection limit were assumed to be at the 
level of detection. 
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4.11.4 Scenario study ASG 
The feeding regime as used in the study of Kan et al. (2003) was used with the data from the National 
Control Plan for Animal Feed. This regime consisted of concentrated feed, silage, and grass pellets. 
4.12 Results 
Data on intake and PAH concentrations were used to calculate the exposure of the cows and 
subsequently the expected concentrations in milk, based on carry-over rates. These concentrations 
were used to estimate the exposure of the consumer, based on a milk consumption of 1.5 liters per day. 
Calculated human total intake of PAHs for all scenarios is presented in figure 1. From the worst case 
scenarios based on maximum concentrations in feed ingredients, winter scenario 3 resulted in the 
highest calculated intake for humans of PAHs. Scenario ASG resulted in the second highest human 
intake of PAHs. 
Based on median concentrations, the scenarios did not result in large differences of PAH intake as 
compared to the worst case scenarios. Again, winter scenario 3 resulted in the highest intake of PAHs, 
but by a very slight difference (0.016 µg/kg bw/day for WS3 versus 0.015 µg/kg bw/day for WS1 and 
WS2). For summer scenario 2, no calculation could be made based on median concentrations, since 
data were obtained from literature and no range was available. 
Distribution of PAHs for the worst case scenarios is presented in figure 2. The calculated intake in the 
scenarios consisted predominantly of PAHs phenanthrene, fluoranthene and pyrene. 
4.12.1 Scenario Winter 
With increasing intake of grass pellets in winter scenarios 1-3, the contribution of phenanthrene 
decreased, while the contribution of fluoranthene and pyrene increased. Distribution of the higher 
molecular PAHs indicated an increase in the contribution of chrysene and dibenzo(a)anthracene with 
increasing intake of grass pellets.  
4.12.2 Scenario Summer 
Summer scenarios 1 and 2 show the impact on risk assessment of calculation with or without data for 
fresh grass. Using data from literature, the contribution of fresh grass to the total intake of PAHs is 
73%. In the summer scenarios, total intake also mainly exists of phenanthrene, fluoranthene and 
pyrene. 
4.12.3 Scenario study ASG 
The scenario study ASG results in the second highest calculated total intake of PAHs. Distribution of 
PAHs is similar to the winterscenario 3. 
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Figure 1:  Calculated total human intake of PAH, based on maximum and median concentrations of PAHs in 
animal feed ingredients. Intake in µg/kg bw/day. 
 
4.12.4 Comparison of calculated PAH intake with reference values 
Although the lower molecular PAHs contribute most to the total calculated human intake, the RfDs for 
these PAHs are not exceeded according to this calculation (table 3), the margin is over a factor 1000. 
In contrast, the lowest ‘virtually safe dose’ (0.14 ng/kg bw/day, US-EPA) for benzo(a)pyrene is 
exceeded by the calculated human intake by a factor of up to 2.75 for scenario ASG (figure 3). Based 
on medians, this ‘safe’ dose is exceeded for winterscenario 1 and scenario ASG. The calculated intakes 
do not exceed the VSD of 0,5 ng/kg bw/day as set by RIVM, either based on maximum or median 
concentrations.  
The low molecular PAHs contribute up from 72% to 80% to the total calculated human intake of 
PAHs. However, the RfDs for these PAHs are not exceeded (table 3). The margins between calculated 
intake and the RfDs are over a factor 1000. In contrast, for BaP, the only carcinogenic PAH for which 
a VSD has been derived, the calculated intake exceeds the US-EPA VSD. The RIVM VSD for PAHs 
of 0.5 ng/kg bw/day (5 ng/kg bw/day for only BaP) is not exceeded. 
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Figure 2:  Contribution of individual PAHs to the calculated concentrations in milk for the worst case scenarios. 
Distribution in percentages. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-c,d]pyrene, 
PYR=Pyrene. 
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Figure 3:  Calculated total human intake of Benzo(a)Pyrene, based on maximum and median concentrations of 
BaP in animal feed ingredients. Intake in µg/kg bw/day. For comparison, the ‘virtually safe dose’ for 
Benzo(a)Pyrene is also presented. 
 
Table 3:  Overview of calculated intakes of Benzo(a)Pyrene by humans and comparison to the reference values. 
Only PAHs for which a reference limit is derived are presented. Reference values and intakes are in µg/kg 
bw/day. Data on calculation and all PAHs can be found in ANNEXES I-VII. ACE=Acenaphthene, 
BAP=Benzo[a]pyrene, PHE=Phenanthrene, FLU=Fluoranthene, PYR=Pyrene. * Value is not an RfD but a 
‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 1*10-6.  
PAH: ACE PHE FLU PYR BAP 
RfD: 60 40 40 30 0.00014* 
Worst case scenario winter 1       
Intake human 0.002 0.0106 0.0018 0.0027 0.0002 
Ratio RfD/intake human 30000 3774 22222 11111 0.70 
Worst case scenario winter 2       
Intake human 0.0029 0.0242 0.018 0.0128 0.0002 
Ratio RfD/intake human 20690 1653 2222 2344 0.70 
Worst case scenario winter 3       
Intake human 0.0038 0.0378 0.0342 0.0229 0.0003 
Ratio RfD/intake human 15789 1058 1170 1310 0.47 
Worst case scenario summer 1       
Intake human 0.0006 0.0035 0.0007 0.0009 0.0001 
Ratio RfD/intake human 100000 11429 57143 33333 1.40 
Worst case scenario summer 2       
Intake human 0.0007 0.0116 0.0032 0.0053 0.0001 
Ratio RfD/intake human 85714 3448 12500 5660 1.40 
Scenario ASG         
Intake human 0.0025 0.032 0.0345 0.0218 0.0004 
Ratio RfD/intake human 24000 1250 1159 1376 0.35 
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4.13 Discussion 
The Dutch Food and Consumer Product Safety Authority (VWA) has the incentive to include certain 
contaminants in the yearly National Control Plan for Animal Feed based on risk assessments. Up to 
recent years, PAHs were included in the National Control Plan for Animal Feed, but there is no legal 
obligation to monitor PAHs. The current (initial) risk assessment was undertaken to provide material 
to start the discussion on continued inclusion of PAHs in this National Control Plan. 
The nature of the toxicological profile of PAHs indicated that a distinction has to be made between the 
low and high molecular PAHs. The high molecular PAHs, of which BaP is the most studied one with 
its strongest carcinogenic and mutagenic potency of the PAHs, are generally considered critical for the 
risk assessment. This is because exposure to PAH in food is almost exclusively to a mixture of PAH 
which includes genotoxic and carcinogenic PAHs (ATSDR, 1995; SCF, 2002; WHO, 2002). These 
considerations are based on the total diet. However focussing on animal products (edible tissues and 
milk) only the profile of PAHs might be different due to the differential transfer of the individual 
PAHs. In addition the PAHs are extensively metabolised in vivo (Cavret et al., 2004), there is evidence 
that the metabolites of the high molecular PAHs are transferred at a higher rate to milk than the 
original compounds (Lutz et al., 2005). These metabolites are important because the carcinogenic 
potency of the high molecular PAHs can be attributed (at least partly) to these metabolites (ATSDR, 
1995). 
Whereas the transfer of the high molecular PAHs to edible tissues is generally low, transfer of the low 
molecular PAHs from animal feed to milk (and other edible tissues) will occur. This is illustrated by 
the results from the study of Kan et al. (2003) indicating that the low molecular PAHs do carry over to 
milk. The thus obtained transfer factors are influenced by the study design and should be considered 
carefully, but are nevertheless useful in combination with data from other studies by Grova et al. 
(2001) and Lutz et al. (2005). Interestingly Lutz et al. (2005) included the metabolites in their analysis. 
Further research on transfer factors and the formation and carry-over of metabolites is clearly needed. 
The PAH concentration in animal feed as obtained by the National Control Plan for Animal Feed 
revealed that a usual pattern of PAHs was present in the feed commodities, e.g. the concentration of 
low-molecular PAHs was higher than the  high-molecular PAHs. To (roughly) estimate the human 
intake of PAHs via milk some exposure scenario’s of lactating cows were calculated. In these 
scenario’s PAH concentrations in feed commodities were obtained from the National Control Plan and 
some additional literature sources. Feed consumption data were taken from a review by Raamsdonk et 
al (in preparation). Transfer of PAH was estimated based on the study by Kan et al (2003) and relevant 
literature (Grova et al., 2001; Lutz et al., 2005). 
The scenarios were designed according to the model developed by Raamsdonk et al. (2004). The 
designs varied reflecting the effect of the use of different feed ingredients in different seasons with 
different levels of PAH contamination. The impact of feeding of relatively high contaminated grass 
pellets in feeding regimes was evaluated in the winter scenarios. Additionally, the contribution of fresh 
grass was evaluated in the summer scenarios. Calculating these scenario’s emphasises the need for a 
complete data set. For example, no data on PAH content of fresh grass were available, data from 
literature was used instead. For silage only two samples of grass silage were analysed in the National 
Control Plan, whereas grass and mais silage are an important part of the animals diet. Thus, absence of 
a complete dataset on PAH concentrations which proportionally covers all feeding ingredients is 
severely hampering the use of the monitoring data from the National Control Plan. If future data from 
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monitoring programs like these should be more suitable for risk assessment, the design of these 
programs should be changed. 
To estimate the human exposure the milk consumption volume from EMEA (standard food basket for 
the safety assessment of veterinary medicinal products) was used. The standard 1.5 liters of milk 
consumed on a daily basis are worst case, but come close to the high intake (large portion size) by 
some Dutch consumers (1.1 liters VCP 97/98). 
Based on maximum concentrations, the outcome of the scenarios showed higher variety in outcome 
than based on median concentrations, with winter scenario 3 resulting in the highest calculated total 
intake of PAHs. The difference in outcome between scenarios based on maximum and median PAH 
concentrations indicated that the used maximum concentrations indeed provide a worst case scenario.  
Inclusion of grass pellets in the feeding regime contributes highly to the calculated total intake of 
PAHs. The high percentage of fresh grass in summer scenario 2 feeding regime does not result in such 
high calculated total PAH intake as compared to the winter scenario 3. This is an indication that the 
high contribution of PAHs from grass pellets could be due to the contamination during the drying 
process in the production of the pellets. However, this remains to be determined. The scenario ASG 
also included grass pellets and resulted in the second highest calculated total intake of PAHs. This 
indicates that scenario ASG is representative for a worst case scenario. 
To evaluate the consequence of the lack of data on fresh grass, summer scenarios 1 and 2 were 
calculated. For summer scenario 2, data on PAH concentrations in non-contaminated grass were used. 
This resulted in a 3.5 fold higher calculated total intake of PAHs. Risk assessment based only on the 
available data from the National Control Plan would therefore result in largely underestimating the 
actual PAH intake in summer. 
Distribution of the PAHs in aminal products is similar for all scenarios. The PAHs phenanthrene, 
fluoranthene and pyrene contribute more than 75% to the calculated total intake of PAHs. This 
distribution shifts towards fluoranthene when more grass pellets are used in the winter scenarios and in 
scenario ASG. This indicates that from PAHs in grass pellets, fluoranthene contributes the highest to 
the calculated total PAH concentration in milk. In the summer scenarios, the contribution of pyrene 
increases for summer scenario 2, indicating that from PAHs in fresh grass, pyrene contributes the 
highest to the calculated total PAHs concentration in milk. 
No information on effects of PAHs on cows could be found in the reviewed literature. Calculated 
intake of PAHs by cows is 65 to 1000 times higher than the calculated intake by humans (data not 
shown). Given the shorter lifespan of cows, comparison to the human RfD is not considered relevant. 
However, the higher calculated intake could still be of importance. Cancer of the gastro-intestinal tract 
is indeed seen in cows (personal comment RIKILT pathologist Dr. Maria Groot), which could be an 
indication for carcinogenic potential of compounds present in animal feed. 
The margin between the calculated human intake and the RfDs for non-carcinogenic effects are over a 
factor 1000. Although combination effects of interacting PAHs could occur, the margin is very high 
and the risk of non-carcinogenic effects from PAHs originating from feed seems to be minimal. In 
contrast, the VSD of 0.14 ng/kg bw/day for BaP (US-EPA based on carcinogenic risk of 1*10-6) is 
exceeded for the winter scenarios (factor 1.85 for WS3) and for scenario ASG (factor 2.75). Based on 
median concentrations this dose is exceeded for winter scenarios 1 and scenario ASG. The calculated 
intakes do not exceed the VSD of 5 ng BaP/kg bw/day (0.5 ng/kg bw/day for total PAHs) as set by 
RIVM, either based on maximum or median concentrations.   
Exceeding the VSD seems contradictory with the data from Kan et al., (2003) where no carcinogenic 
PAHs were detected in milk above the detection limits of 0.1 ng/g. Calculated BaP concentrations in 
the scenario’s were in the range of 4 to 14 ng/l and thus higher than the detection limits. However, the 
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transfer rate used for the calculated human intake was taken from the study of Grova et al. (2002), 
which showed a transfer of 0.2% BaP related activity from radiolabeled PAHs from feed to milk in 
goat. Since BaP was not detected in cows milk in other studies, it could be possible that the transfer in 
cows is different than in goats. BaP metabolites are usually not analysed in milk, so it seems likely that 
the 0.2% BaP related radioactivity results from transferred BaP metabolites. In this case, it is not clear 
to what extend the VSD of 0.14 ng/kg bw/day for BaP can be applied. However, the VSD is exceeded 
for the worst case scenarios, so detailed analysis on occurrence and effects of metabolites of BaP (and 
other PAHs) is recommended for facilitating more accurate risk assessment. 
Notwithstanding the limitations of the initial risk assessment and it (worst case) assumptions it can be 
concluded that there are good reasons to include PAHs and its metabolites into the National Control 
Plan for Animal Feed. To obtain more information on the actual exposure of animals and humans the 
design of the monitoring schedule needs to be carefully reconsidered. In addition, more information on 
the transfer of PAHs from feed to animal products is needed. 
4.14 Conclusions 
4.14.1 Toxicology 
• Data on non-carcinogenic effects are very limited. Similar applies on the oral carcinogenic 
potential of PAHs other than BaP. 
4.14.2 Scenarios 
• The scenario ASG seems representative of a worst case scenario; 
• From PAHs in grass pellets, fluoranthene contributes the highest to the calculated total PAH 
concentration in milk; 
• From PAHs in fresh grass, pyrene contributes the highest to the calculated total PAHs concentration 
in milk. 
4.14.3 Transfer from feed to animal products 
• Data on transfer rates of PAHs to cows milk and other animal products are very limited;Metabolism 
is a factor in the transfer of PAHs from feed to food. It is likely that PAHs with more than 5 rings 
are transferred as metabolites; 
• Artificially dried roughage feed, such as grass pellets, contribute largely to the total concentration 
of PAHs in milk. 
4.14.4 Human exposure 
• The calculated human intake of PAHs from animal feed via milk is far below the RfDs set for non-
carcinogenic effects; 
• Calculated transfer of high-molecular PAHs from feed to cows milk results exceeding the ‘virtually 
safe dose’ for Benzo(a)Pyrene up to a factor 2.75 for human consuming this milk. Based on the 
data in literature, this could be the result from carry-over of metabolites. 
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4.14.5 Animal exposure 
• Calculated intake of PAHs by cows is 65 to 1000 times higher than the calculated intake by 
humans, while their weight is 4-8 times higher, which could indicate a potential risk for animal 
health. 
4.14.6 National Control Plan for Animal Feed 
• The current analysis of PAHs in food should not be expressed solely in Benzo(a)Pyrene 
equivalents; 
• Analysis of PAHs in animal products should also include metabolites of PAHs; 
• The design of the National Control Plan is not compatible with the use in risk assessment. Other 
feed ingredient categories should be included, such as the staple compound feed ingredient cereal, 
and fresh grass; 
• In addition, the monitoring design should be adapted to provide a stronger statistical basis for risk 
assessment, by taking more samples for the animal feed categories other than oils/fats and dried 
roughage. 
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5  Volatile Organic Compounds 
5.1 Introduction 
Volatile organic compounds (VOCs) are simple hydrocarbons which are liquid at room temperature 
and highly volatile, and classified by their boiling points (between 50˚ and 260˚ C, WHO definition). 
They originate from crude oil and derived products. In food production, they are used as solvents for 
extracting oil from oilseeds such as soy and rape, and flavourings from natural flavouring materials. 
For a specification of VOCs assessed in this chapter see table 1.  
 
Table 1:  Name, log P value, CAS number and structural formula of VOCs assessed in this chapter. * BTEX is the 
abbreviation often used for the group of aromates Benzene, Toluene, Ethylbenzene and Xylene. ** The obtained 
log P values suggest an appreciable oral bioavailability (logP around 3) of most of these compounds, with the 
exception of acetone and ethylacetate.  
Compound Log p** Cas number Structural formula 
AROMATES (BTEX*)    
Benzene (BNZ) 2.13 71-43-2 
C6H6 
Toluene (TOL) 
(methylbenzene) 
2.73 108-88-3 
C7H8 
Ethylbenzene (EBZ) 3.15 100-41-4 
C8H10 
Ortho-xylene (OXL) 
(1,2 dimethylbenzene) 
3.12 95-47-6 
C8H10 
Meta-xylene (MXL) 
(1,3 dimethylbenzene) 
3.2 108-38-3 
C8H10 
Para-xylene (PXL) 
(1,4 dimethylbenzene) 
3.15 106-42-3 
C8H10 
ALKANES    
n-Pentane (PEN) 3.39 109-66-0 
C5H12 
n-Hexane (HEX) 3.9 110-54-3 
C6H14 
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n-Heptane (HEP) 4.66 142-82-5 
C7H16 
n-Octane (OCT) 5.18 111-65-9 
C8H18 
SPECIFIC ALKANES     
1-Hexene (HXE) 3.39 592-41-6 
C6H12 
Cyclohexane (CHX) 3.44 110-82-7 
C6H12 
OTHER    
Acetone (ACT) -0.24 67-64-1 
C3H6O 
Ethylacetate (EAC) 0.73 141-78-6 
C4H8O2 
 
In Europe, the use of VOCs in food is regulated by Directives 88/344/EEC, 92/115/EEC, 94/52/EEC 
and 97/60/EEC. ANNEX VIII shows the list of VOCs which are currently allowed for use as 
extraction solvents in the production of foodstuffs and food ingredients.  
In feed, the use of extraction solvents is regulated under Regulation 1831/2003 (additives for use in 
animal nutrition). In this regulation, the extraction solvents classify as processing aids under definition 
2h: ‘’processing aids’ means any substance not consumed as a feeding stuff by itself, intentionally 
used in the processing of feeding stuffs or feed materials to fulfill a technological purpose during 
treatment or processing which may result in the unintentional but technologically unavoidable 
presence of residues of the substance or its derivatives in the final product, provided that these 
residues do not have an adverse effect on animal health, human health or the environment and do not 
have any technological effects on the finished feed’. In short: if the residues do not pose a risk for 
(end)consumers of the ingredients, any compound can be used during the production of animal feed. 
In this document, the potential risks related to the presence of residues of VOCs in feed ingredients, as 
measured in the National Control Plan for Animal Feed in previous years, were evaluated. 
5.2 Occurrence of residues of VOCs in foods 
The industry has an economical benefit from recovering solvents from the extracted foodstuffs as 
much as possible, and will thus refine of the oils and fats further after extraction from the seeds. In 
foods for human consumption, the occurrence of residues will usually be low as required by Directives 
88/344/EEC, 92/115/EEC, 94/52/EEC and 97/60/EEC. Due to their volatile nature, remaining 
concentrations of extraction solvents in food commodities can be even further reduced due to contact 
with the air and processing steps that involve heating, however evaporation of VOCs from oil may be 
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hampered because of its high surface tension. Residues of extraction solvents in food are generally 
considered to be easily metabolised in vivo and thus not to be a problem for the safety of the 
consumer. More emphasis is put on the exposure to VOCs by inhalation of workers in the vegetable oil 
extraction industry.  
In the case of animal feed and feed ingredients however, materials usually are not highly refined, and 
concentrations of extraction solvents in feed ingredients may be expected to be high. 
 
Limited information on the occurrence of VOCs in food and commodities could be found. In a 
Swedish survey, acetone was found in concentration of 18-226 mg/l in cow’s milk and 2 mg/kg in 
beans (unknown reference cited by Kloet, 2002). In human blood plasma background concentrations 
of 1-2 mg/l can be found, much higher concentrations can be observed during fasting;  45 mg/l in 
plasma has been recorded (unknown reference cited by Kloet, 2002). In humans, acetone is also 
endogenously produced during metabolisation of foods and in particular fats. In ruminants, acetone is 
produced in significant amounts during microbial fermentation in the fore stomach system (personal 
comment professor Fink-Gremmels, University of Utrecht). 
 
Fleming-Jones and Smith (2003) reported the results of an study of US Food and Drug Administration 
(FDA) on VOCs in 70 foods, which included animal products, over a 5 year period in the USA (1996-
2000). VOCs were found in at least one sample of all foods tested, although no single compound was 
found in each of the foods. The total amount of VOCs found in a single food item over the 5 year 
period ranged from 24 to 5328 µg/kg. In creamed corn (canned) the lowest concentrations were 
observed and in cheddar cheese the highest. Benzene was found in all but 2 food products, with 
concentrations ranging from 1 to 190 µg/kg. The highest concentration was found in fully cooked 
ground beef, the average concentration was 40 ppb in the 12 analysed samples of fully cooked ground 
beef. Benzene concentrations above 100 µg/kg were also seen in at least one sample each of cola (138 
µg/kg). Benzene formation in soft drinks (and other products) can occur when ascorbic acid (vitamin 
C) and the preservative sodium benzoate react together. Interestingly, in primary products such as raw 
bananas (132 µg/kg), and cole slaw (102 µg/kg) also high concentrations of benzene were found. 
According to the study of Hattemer-Frey et al. (1990, cited by ATSDR, 2005) benzene in products of 
plant origin primarily results from air-to-leaf transfer. 
 
Contradictory results have been found in eggs. In the ATSDR draft Toxicological profile on benzene, it 
was mentioned that in an US-EPA inventory from 1982 concentrations up to 2100 µg/kg were found in 
uncooked eggs and 500–1900 µg/kg in hard-boiled eggs. Other cited studies reported concentrations 
under 2 µg/kg (McNeal et al., 1993, cited by ATSDR, 2005). 
 
The total concentration of benzene on exposed food crops consumed by humans was estimated to be 
587 ng/kg (Hattemer-Frey et al. 1990, cited by ATSDR, 2005). In the EU Risk Assessment Report (EU 
RAR, Chemicals Bureau, 2003, draft) it was stated that ‘Indirect exposure via the environment has 
been calculated for the uptake of benzene via ambient air, drinking water, vegetables, milk, and meat. 
For all scenarios the most relevant contribution to the total daily dose is the uptake via air (96 - > 
99%). Drinking water and fish consumption contribute 0.1 - 2% to the exposure. All other sources of 
exposure (milk, meat and vegetables) can be regarded as not significant.’  
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5.3 Toxicological profile 
Due to their volatile nature, most toxicological studies on VOCs focus on exposure via inhalation. In 
the toxicological profile of this initial risk assessment, the focus is on oral exposure.  Kinetics were 
only described for benzene and hexane, being the most toxic compound and most abundant compound 
present in animal feed ingredients (see paragraph 5.5), respectively.  
5.3.1  Aromates (BTEX) 
An elaborate desription of alkanes is made in the risk assessment of mineral oil in animal feed 
ingredients (see chapter 3). In short, fractions of alkanes are identified by dividing aromatic and 
aliphatic hydrocarbons by structure and further subdividing on the basis of equivalent carbon number 
index (EC). This index is equivalent to the retention time of the compounds on a boiling point GC 
column (non-polar capillary column), normalized to the n-alkanes. The aromatic fraction EC5-9 was 
considered by the Total Petroleum Hydrocarbons Criteria Working Group, Toxicology Technical 
Action Group (TPHCWG) to contain ethylbenzene, toluene, styrene and o,m,p-xylene. Benzene was 
excluded due to its carcinogenic properties and is discussed separately. An RfD of 0.2 mg/kg bw/day 
was set by TPHCWG for the whole fraction (cited by RIVM, 2001) 
5.3.1.1 Benzene  
Consumption of foods or liquids containing high concentrations of benzene can cause vomiting, 
irritation of the stomach, dizziness, sleepiness, convulsions, tachycardia, coma, and death. The health 
effects that may result from the consumption of lower concentrations of benzene are not known 
(ATSDR, 2005). Benzene is classified as a carcinogen (IARC, 1987). Exposure to benzene has been 
associated with development of a particular type of leukaemia, denoted acute myeloid leukaemia 
(AML). 
 
At present it is not know whether or not benzene can induce adverse human health effects after long-
term oral exposure. In rats and mice, exposure to food or water contaminated with benzene was found 
to affect the haematopoietic and the immune system, furthermore it caused several types of cancer at 
25 mg/kg bw/day, such as Zymbal gland carcinomas, oral cavity squamous cell papillomas and 
carcinomas, malignant lymphomas and Harderian gland adenomas. (ATSDR, 2005) 
 
Kinetics 
The toxicokinetics of benzene have been studied in both animals and humans. The key findings 
suggest that benzene is absorbed via all exposure routes (inhalation, dermal and oral) with inhalation 
as the most important route of exposure. After absorption, benzene is rapidly distributed, with the 
highest concentrations in fat and in lipid rich tissues compared to blood. In vivo, benzene is rapidly 
metabolized and the metabolites are excreted mainly in the urine following phase-II-conjugation. 
Formation of the ultimate toxic species of benzene requires oxidative metabolism of benzene, the 
metabolic pathway is comparable for humans and animals. The liver is the major site of benzene 
metabolism, but metabolism in the bone marrow may be associated with the haematotoxic and 
leukaemogenic effects of benzene (EU RAR, 2003, draft).  
It has been suggested that benzene toxicity works via a multiple metabolite type of mechanism, 
meaning that not just one metabolite is responsible for benzene toxicity, but multiple metabolites are 
involved. (EU RAR, 2003, draft).  
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IARC classified benzene in 1987 as a human carcinogen class I. They found in three independent 
cohort studies evidence of an increased incidence of acute nonlymphocytic leukaemia in workers 
exposed to benzene via inhalation. Other studies in rats and mice showed carcinogenic effects after 
oral, inhalation and intraperitoneal exposure. 
 
Reference limits 
RIVM (2001): MPR 0.0033 mg/kg bw/day. 
RIVM has derived in 2001 a provisional oral maximum permissible risk dose (MPR) of 0.0033 mg/kg 
bw/day. This value was derived from a human occupational cohort study, in which 748 were exposed 
to benzene via inhalation for at least one day over 9 years cohort study, using route-to-route 
extrapolation. The toxicological endpoint in the study was leukemia (RIVM, 2001). 
 
WHO (1993, 2003):  drinking water guideline value 0.01 mg/l. 
WHO derived a guideline value of 0.01 mg/l in drinking water, using a linear extrapolation model 
(because of statistical lack of fit of derivation some of the data with the linearized multistage model) 
applied to leukaemia and lymphomas found in female mice, and oral cavity squamous cell carcinomas 
found in male rats in a 2-year gavage study in rats and mice (WHO, 2003, original assessment in 
1993). The 1993 Guidelines estimated the range of benzene concentrations in drinking-water 
corresponding to an upper-bound excess lifetime cancer risk of 10-5 to be 0.01– 0.08 mg/l based on 
carcinogenicity in female mice and male rats. As the lower end of this estimate corresponds to the 
estimate derived from epidemiological data, which formed the basis for the previous guideline value 
of 0.01 mg/l associated with a 10-5 upper-bound excess lifetime cancer risk, the guideline value of 
0.01 mg/l was retained. Due to the carcinogenicity of benzene, no TDI was set. 
 
EPA (2005): RfD 0.004 mg/kg bw/day 
US-EPA derived an oral reference dose (RfD) for benzene of 0.004 mg/kg bw/day, based on the results 
of BMD modelling of ALC data from the occupational epidemiologic study of Rothman et al. 
(1996a), in which workers were exposed to benzene by inhalation. The resulting BMCL of 7.2 ppm for 
decreased lymphocyte count was converted to 23.0 mg/m3 and adjusted from intermittent to 
continuous exposure (BMCLADJ=8.2 mg/m3). Route-to-route extrapolation methodology was applied 
to convert from inhalation to equivalent oral exposure, resulting in an equivalent oral dose rate of 1.2 
mg/kg/day. This value was divided by a total uncertainty factor of 300 (3 for effect-level extrapolation, 
10 to protect sensitive individuals, 3 for subchronic-to-chronic extrapolation, and 3 for database 
deficiencies). EPA also classified benzene as carcinogenic, and derived from epidemiological studies 
the drinking water concentration of 1-10 µg/L at specified risk levels of 1 in 10-6 for leukaemia (2000): 
 
IARC (1987): Carcinogenic group I. 
IARC classified benzene in 1987 in group I; carcinogenic for humans.  
 
The lowest reference value for oral exposure of 0.0033 mg/kg bw/day as derived by RIVM in 2001 
was used in this risk assessment. 
5.3.1.2 Toluene 
Studies of the effects of oral exposure to toluene are limited. Only one study could be found regarding 
health effects in humans after oral exposure to toluene, and there are only a minimal number of animal 
studies.  Adverse effects include cardiovascular, haematological, hepatic, and renal effects in animals 
exposed orally to toluene at dosage levels up to 2500 mg/kg/day for 13 weeks, or 590 mg/kg/day for 6 
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months (Hsieh et al., 1989; NTP, 1990; Wolf et al., 1956, cited by ATSDR, 2000). Oral exposure of 
rats or mice to toluene doses of 2500 mg/kg/day for 13 weeks was not found to induce any 
musculoskeletal, gastrointestinal or respiratory effects (NTP, 1990, cited by ATSDR, 2000).  
 
Neither statistically significant respiratory, gastrointestinal, haematological, musculoskeletal effects, 
nor effects on the adrenal or thyroid glands, nor on the histology or weight of the spleen or thymus, 
were reported in mice or rats after oral exposure to toluene at dosage levels up to 2500 mg/kg/day for 
13 weeks (NTP, 1990) or 650 mg/kg/day for 6 months (Wolf et al., 1956, cited by ATSDR, 2000). 
 
Increased relative heart weight, increase in liver weight, increases in the relative kidney weights and 
neurological effects have been recorded after oral exposure (ATSDR, 2000). 
 
Reference limits 
WHO (1993, 2003): TDI 0.223 mg/kg bw/day. 
WHO has derived a TDI of 0.223 mg/kg bw/day, based on a LOAEL of 312 mg/kg of body weight per 
day for marginal hepatotoxic effects observed in a 13-week gavage study in mice, correcting for 5 
days per week dosing and using an uncertainty factor of 1000 (100 for inter- and intraspecies variation 
and 10 for the short duration of the study and use of a LOAEL instead of a NOAEL) (WHO, 2003, 
original assessment in 1993). 
 
RIVM (2001): TDI 0.223 mg/kg bw/day. 
RIVM has adopted the WHO (1993,1996) TDI of 0.223 mg/kg bw/day in 2001. 
 
ATSDR (2000):  MRL 0.02 mg/kg bw/day for intermediate duration exposure (15–364 days).  
ATSDR did not derive an Minimum Risk Level (MRL) for chronic oral exposure as they found no 
suitable data available for toluene. An MRL of 0.02 mg/kg bw/day has been derived for an 
intermediate duration (15–364 days) of oral exposure to toluene. This MRL was derived from a 
LOAEL of 5 mg/kg/day based on regional increases in monoamine neurotransmitters in the brains of 
CD1 mice exposed to toluene through their drinking water for 28 days (Hsieh et al. 1990b, cited by 
ATSDR, 2000). 
 
EPA (2005): RfD 0.08 mg/kg bw/day. 
US-EPA has derived an RfD of 0.08 mg/kg bw/day in 2005, based on a BMDL of 238 mg/kg/day for 
increased kidney weight in rats. 
 
The lowest RfD of 0.08 mg/kg bw/day as derived by EPA in 2005 was used in this risk assessment. 
5.3.1.3 Ethylbenzene 
There are no reliable data on the effects in humans after oral exposure to ethylbenzene. One oral 
intermediate-duration study in rats was found in the literature (Wolf et al. 1956), in which female rats 
were orally exposed to 13.6-680 mg/kg/body weight ethylbenzene by gavage for 6 months. Effects 
that were found were increased kidney and liver weight and histopathological changes in both organs. 
Some changes were also found in heamatological parameters. However, no conclusions could be 
drawn 
from these results because of serious weaknesses in the methodology and reporting of the data 
(ATSDR, 1999). 
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The only available reproduction study with animals indicates that acute oral exposure to 500 or 
1000 mg/kg ethylbenzene decreases peripheral hormone levels and may block or delay the estrus cycle 
in female rats during the diestrus stage (Ungvary, 1986, cited by ATSDR). Decreased levels of 
hormones, including luteinizing hormone, progesterone, and 17 β-estradiol, were accompanied by 
uterine changes. These consisted of increased stromal tissue with dense collagen bundles and reduced 
lumen. No dose response was noted. The study limitations included lack of rationale for dose 
selection, use of only two doses, small number of test animals, and no statistical analysis of the data 
(ATSDR, 1999). 
 
In inhalation studies, ethylbenzene has been shown to have carcinogenic properties. An NTP-
sponsored 2-year inhalation bioassay in rats revealed a significant increase in interstitial cell adenomas 
and bilateral testicular adenomas, but not mice at 750 mg/kg ethylbenzene (NTP, 1999). IARC (2000) 
concluded that ethylbenzene is possibly carcinogenic to humans (group 2B) based on inadequate 
evidence in humans and sufficient evidence in animals. 
 
Reference limits 
RIVM (2001): TDI 0.1 mg/kg bw/day. 
RIVM derived a TDI of 0.1 mg/kg bw/day in 2001, based on the TDI assessment of 1991 (which 
resulted in a TDI of 136 µg/kg bw/day based on a NOAEL of 136 mg/kg bw/day for liver and kidney 
toxicity in rats). The 1991 TDI was adjusted for exposure duration (back calculation from the NOAEL 
for 5 days/week to the value for 7 days/week). The adjusted NOAEL was 97 mg/kg bw/day. Applying 
an UF of 1000 (as was done in 1991) resulted in a TDI of 100 µg/kg bw/day. 
 
WHO (1993, 2003):  TDI 0.097 mg/kg bw/day. 
WHO has derived a TDI of 0.097 mg/kg of body weight/day, using the same studie and extrapolation 
factor as was done by RIVM (WHO, 2003, original assessment in 1993). 
 
EPA (1991): RfD 0.1 mg/kg bw/day. 
US-EPA has set an RfD of 0.1 mg/kg bw/day based on a NOEL of 97.1 mg/kg/day for increased 
weight and histopathological changes in the liver and kidneys of rats (EPA, 1991). Confidence in the 
RfD is low because in the study used for setting the RfD (Wolf et al., 1952)2, rats of only one sex 
were tested and the experiment was not of chronic duration. Confidence in the supporting database is 
low because other oral toxicity data were not found. 
 
ATSDR (1999): no derived MRLs. 
ATSDR derived no acute-, intermediate-, or chronic-duration oral MRLs for ethylbenzene due to lack 
of appropriate data (ATSDR, 1999). 
 
IARC (2000): carcinogenic group 2B. 
IARC classified in 2001 ethylbenzene as category 2B; possibly carcinogenic to humans based on 
sufficient evidence for the carcinogenicity in experimental animals (inhalation studies). 
 
The adjusted TDI of 0.1 mg/kg bw/day from RIVM (2001) was used in this risk assessment. 
                                                     
2 The TDI of RIVM and WHO were based on the same study. 
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5.3.1.4 Xylenes 
NTP found a 5–8% decrease in body weight gain (which they considered biologically not significant) 
and unexplained reduced survival rate in male F344 rats at 500 mg/kg (NTP, 1986). In a 90-day 
gavage study using xylenes and individual isomers mild nephropathy was found in female rats (Condie 
et al., 1988, cited by RIVM, 2001). Transient hyperactivity was noted after gavage administration in 
male and female B6C3F1 mice at a dose of 1000 mg/kg/day (NTP, 1986, cited by ATSDR, 2005). 
 
Reference limits 
RIVM (2001): TDI 0.15 mg/kg bw/day. 
RIVM derived in 2001 a TDI of 0.15 mg/kg bw/day based on a LOAEL of 150 mg/kg bw/day for 
increased incidence of mild chronic nephropathy in female rats in a  90-day gavage study using mixed 
xylenes and individual isomers (Condie et al., 1988, cited by RIVM, 2001). The response at this dose 
was marginal only and it was considered that the NOAEL would be only slightly lower. The LOAEL 
was divided by an uncertainty factor of 1000, including inter- and intraspecies factors of 10, and an 
extra factor of 10 for limited duration of the pivotal study. Because of the mild nature of the effect 
seen at the LOAEL, the use of an extra factor for the use of a LOAEL was not considered necessary. 
 
WHO (1993, 2003): TDI 0.179 mg/kg bw/day. 
WHO derived a TDI of 0.179 mg/kg bw/day, based on a NOAEL of 250 mg/kg of body weight per 
day for decreased body weight in a 103- week gavage study in rats, correcting for 5 days per week 
dosing and using an uncertainty factor of 1000 (100 for inter- and intraspecies variation and 10 for the 
limited toxicological end-points) (WHO, 2003, original assessment in 1993). 
 
ATSDR (2005): MRL 0.6 mg/kg/day. 
ATSDR derived an MRL of 0.6 mg/kg/day for chronic oral exposure (≥1 year) to mixed xylenes.  
A NOAEL of 500 mg/kg was identified for hyperactivity in mice, but this was not selected as the basis 
for the MRL, because that dose decreased the survival rate in male rats. Therefore, the rat NOAEL of 
250 mg/kg was selected as the basis of the MRL. The NOAEL was first adjusted for discontinuous 
exposure (5 days/7 days), resulting in a duration-adjusted NOAEL of 179 mg/kg/day. An uncertainty 
factor of 100 (10 for extrapolation between animals and humans and 10 for human variability) and a 
modifying factor of 3 were applied to the duration-adjusted NOAEL to account for the lack of testing 
for sensitive neurological end points (the most sensitive effects in inhalation studies and acute oral 
studies). The resulting MRL of 0.6 mg/kg/day is considered to be protective to human health under the 
conditions of chronic oral exposure (>1 year) to mixed xylenes or individual isomers.  
 
The lowest reference value of 0.15 mg/kg bw/day as derived by RIVM in 2001 was used in this risk 
assessment. 
5.3.2 Alkanes 
5.3.2.1 n-Hexane 
It must be noted that the term ‘hexane’ is used for two types of solvents. First of all, there is the pure 
form of aliphatic alkane as illustrated in table 1, this type is usually referred to as n-hexane. Then there 
is the technical grade of hexane, a mixture of isomers of hexane. This latter type is mostly referred to 
as technical grade hexane, but the simple term ‘hexane’ is also used. In this document, we focus on the 
effects and reference value for n-hexane.  
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n-Hexane is known to exert peripheral neuropathy after oral exposure. Studies in rats showed that a 
metabolite of n-hexane (2,5-hexanedione) causes the neuronal damage, and not n-hexane itself 
(ATSDR, 1999). 
 
A study in rats was conducted by Krasavage et al. in 1980 (cited by ATSDR, 1999) comparing oral 
(gavage) administration of n-hexane with its metabolites and technical grade hexane for 90-120 days. 
At 4,000 mg (46.2 mmol)/kg/day, clinical signs of neurotoxicity (severe hindlimb weakness or 
paralysis) were present after 101 days in 3 out of 4 rats. At this dose, also histological evidence of 
tibial nerve alterations (multifocal axonal swellings, adaxonal myelin infolding, paranodal myelin 
retraction) was observed. Clinical signs of neurotoxicity were seen with all of the metabolites at 
different timepoints at equimolar doses of 6.6 mmol/kg bw/day but not with practical grade hexane. 
Time to onset was as little as 16.8 days with 2,5-hexanedione. With practical grade hexane only one rat 
of 5 treated with 4,000 mg/kg/day showed histological lesions. 
 
Kinetics 
No studies were located that specifically addressed absorption of n-hexane after oral exposure in 
humans or animals. Absorption of n-hexane by the oral route in humans can be inferred from the 
appearance of n-hexane in exhaled air and 2,5-hexanedione in urine of volunteers receiving 0.24 or 
0.81 mg/kg via a gastric feeding tube (Baelum et al.1998, cited by ATSDR, 1999). Absorption of 
toxicologically significant amounts by this route can be inferred since neurological effects occurred in 
rats receiving n-hexane by gavage (Krasavage et al. 1980; Ono et al.1981, cited by ATSDR, 1999). 
Significant serum levels of the n-hexane metabolite 2,5-hexanedione were also measured in rats 
receiving n-hexane by gavage (Krasavage et al.1980, cited by ATSDR, 1999). No studies were located 
regarding distribution of n-hexane after oral exposure in humans or animals. 
Little information is available on the metabolism of n-hexane after oral exposure, although it appears 
to be qualitatively similar to that after inhalation exposure. Metabolism of n-hexane takes place in the 
liver. When male Wistar rats were exposed via inhalation to n-hexane at concentrations up to 3,074 
ppm for 8 hours, analysis of urine showed that 2-hexanol was the major metabolite, accounting for 
about 60-70% of the total metabolites collected over the 48-hour collecting period (Fedtke and Bolt 
1987, cited by ATSDR, 1999). This is in contrast to humans, in which the major urinary metabolite is 
2,5-hexanedione (Perbellini et al.1981, cited by ATSDR, 1999). Peak serum concentrations of the n-
hexane metabolite 2,5-hexanedione of 24, 44, and 53 μg/rnL were observed in rats after a single 
gavage exposure to 570, 1,140, and 4,000 mg/kg n-hexane, respectively (Krasavage et al.1980, cited 
by ATSDR, 1999). Serum 2,5-hexanedione concentrations rose slowly to a peak at 12-16 hours and 
returned to baseline by 24 hours. Excretion of n-hexane after oral exposure in humans can be inferred 
from the appearance of n-hexane in exhaled air and 2,5-hexanedione in urine of volunteers receiving 
0.24 or 0.81 mg/kg via a gastric feeding tube (Baelum et al.1998, cited by ATSDR, 1999). No studies 
were located regarding excretion of n-hexane or n-hexane metabolites following oral exposure to n-
hexane in animals (ATSDR, 1999). 
 
Reference limits 
EPA (2005):  provisional RfD of 0.06 mg/kg bw/day. 
US-EPA derived a provisional RfD of 0.06 mg/kg bw/d based on neurological and reproductive effects 
in rats. The provisional RfD is a value that has had some form of Agency review but is not on EPA's 
Integrated Risk Information System (IRIS, 2005). 
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ATSDR (1999): no derived limits. 
ATSDR did not derive an MRL for oral exposure to n-hexane because of the limited database for oral 
exposure to n-hexane and the lack of toxicokinetic data for this route of exposure. 
 
The provisional RfD of 0.06 mg/kg bw/day from EPA was used in this risk assessment. 
5.3.3 Specific alkanes 
5.3.3.1 1- Hexene 
No information could be found on the oral toxicity of 1-hexene. Only few data are cited in the 
Hazardous Substances DataBank (HSDB), which indicate that when inhaled, 1-hexene at a 
concentration of about 0.1% produces CNS depression in humans, with accompanying vertigo, 
vomiting, and cyanosis. It is a low to moderate irritant to the skin, mucous membranes and eyes 
(Clayton & Clayton, 1993-94, cited by HSDB). 
 
Reference limits 
No reference limits were found. 
5.3.3.2 Cyclohexane 
No published data on oral repeated dose toxicity are available (EU RAR, 1999). 
 
Some toxicological effects can be identified from inhalation studies. EPA cited two 90-day whole-
body inhalation studies in mice and rats (DuPont, 1996, cited by EPA, 1993). In mice, clinical signs of 
hyperactivity and marked central nervous system stimulation were the main observed symptoms. The 
clinical observations of response to an auditory alerting stimulus varied as it was diminished in some 
instances and it could not be assessed due to hyperactivity at other periods. In addition, relative liver 
weights were increased. All symptoms diminished during a recovery period of one month. In rats, the 
most common clinical observation was diminished alerting responses in the chamber during exposure. 
This effect was characterized as transient and was not observed immediately after removing the 
animals from the chamber. 
 
Reference limits 
EPA: no derived limits. 
US-EPA has evaluated the noncancer oral toxicity data for cyclohexane, but did not derive a reference 
dose (RfD) because no adequate oral exposure studies of humans or animals exist from which an oral 
RfD may be derived. EPA also determined that there are no adequate data for using route-to-route 
extrapolation from inhalation toxicity studies to derive an RfD. 
5.3.4 Other VOCs 
5.3.4.1 Acetone 
Health effects from long-term oral exposures are known mostly from animal studies. Kidney, liver, and 
nerve damage, an increased incidence of birth defects, and lowered ability to reproduce (males only) 
occurred in animals following long-term exposure. However, these effects occurred at dosages above 
500 mg/kg bw/day. It is not known if the same effects can occur in humans (ATSDR, 1994).  
Direct toxicity of acetone to the digestive system could not be demonstrated. Histological examination 
of the gastrointestinal tract of rats and mice exposed to acetone in drinking water for 13 weeks (Dietz 
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et al. 1991; NTP 1991, cited by ATSDR, 1994) or of rats given acetone in water by gavage for 13 
weeks (American Biogenics Corp., 1986, cited by ATSDR, 1994) did not reveal any treatment-related 
lesions. No studies have been conducted to assess the gastrointestinal effects in humans after oral 
(dietary) exposure to acetone. Only one incident of a man who intentionally drank approximately 200 
mL of pure acetone (≈2241 mg/kg) and who had a red and swollen throat and erosions in the soft 
palate and entrance to the oesophagus has been described (Gitelson et al., 1966, cited by ATSDR, 
1994). 
 
It is worthwhile to mention that acetone may potentiate n-hexane neurotoxicity by decreasing body 
clearance of 2,5-hexanedione (Ladefoged and Perbellini, 1986, cited by ATSDR Toxicological profile 
on hexane, 1999) 
 
Reference limits: 
EPA (2003): RfD 0.9 mg/kg bw/day. 
US-EPA derived in 2003 a reference dose of 0.9 mg/kg-day, based on nephropathy in rats following 
subchronic exposure via drinking water  (Dietz et al., 1991; NTP, 1991), and using an uncertainty 
factor of 1000 (10 for intra-species variation, 3 for inter-species variation, 3 for extrapolation from 
subchronic studies, and 10 to account for database deficiencies). 
5.3.4.2 Ethylacetate 
Only one oral toxicity study could be found. US EPA sponsored in 1986 a 90-day subchronic study of 
ethyl acetate in rats. Four groups of rats (30/sex/group) were gavaged daily with 0, 300, 900 and 3600 
mg/kg/day of ethyl acetate. Six weeks after the initial dosing, 10 rats/sex were subjected to interim 
sacrifice while the remaining rats continued on the dosing regimen until the final sacrifice (90 days). 
Male rats exposed to the high dose (3600 mg/kg/day) of ethyl acetate showed significant toxic effects, 
such as depressed body and organ weights, and depressed food consumption. Female rats exposed to 
the high dose showed slight but nonsignificant depression of above parameters compared with 
controls. The next lower dose (900 mg/kg/day) did not produce any adverse effects in either male or 
female rats and was therefore considered a NOEL.  
Citations on inhalatory and dermal effects in the Hazardous Substances DataBank indicate that ‘Ethyl 
acetate has…. reputation of being one of the least toxic of the volatile organic solvents’. 
 
Reference limits 
EPA (1986): RfD 0.9 mg/kg bw/day. 
EPA derived in 1986 an RfD of 0.9 mg/kg bw/day based on a NOEL of 900 mg/kg bw/day for 
mortality and body weight loss in an oral subchronic study in rat. An uncertainty factor of 1000 was 
applied: 10 for intra- and 10 for interspecies extrapolation, and 10 to extrapolate subchronic to chronic 
exposure (EPA, 1986). 
 
All RfDs and NOAELs/BMDs from which they were derived are summarized in table 2. 
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Table 2:  NOAELs from animal experiments from which reference values for humans were derived. NOAELs in 
mg/kg bw/day. All NOAELs were determined in rats, except for benzene, which is a route-to-route extrapolated 
BMDL from occupational studies (inhalation) in humans. * value is a BMDL. ** value is a LOAEL. 
ACT=Acetone, BNZ=Benzene, EAC=Ethylacetate, EBZ=Ethylbenzene, HEX=Hexane, TOL=Toluene, OXL=O-
Xylene, M+PXL=M+P Xylene. 
 ACT BNZ EAC EBZ HEX TOL OXL M+PXL 
RfD 0.9 0.003 0.9 0.1 0.06 0.08 0.15 0.15 
NOAEL 900 1.2 900 97 4000 238* 150** 150** 
5.4 Human oral exposure 
No data was found on current levels of oral exposure of humans to VOCs. For the most toxic 
compound, benzene, it was concluded in the EU draft RA (2003) that ‘inhalation is the dominant 
pathway for benzene exposure in humans, whereas oral and dermal exposure can be neglected’.  
 
According to Environmental Health Perspectives (EHP, 1996), background concentrations for VOCs 
in human blood range from 70 ppt (styrene) to 1.1 ppb (toluene). This is appointed to non-
occupational inhalation of VOCs, and it is indicated that smoking is an important source of exposure 
to aromatic VOCs. 
5.5 Measurements in feed materials 
Data from the National Control Plan for Animal Feed have been processed and results are shown in 
table 3. Matrices were categorised and maximum concentrations per category were determined. More 
details on the (processing of) data can be found in ANNEX IX Processing of VOC data. 
 
Table 3:  Maximum concentrationof VOCs  in feed ingredient categories as measured in the National Control 
Plan for Animal Feed in the years 2000-2004. Concentrations in µg/kg. Feed ingredient categories are: 
1=Flakes, 2a=Oils/fats-vegetable, 2b=Oils/fats-animal, 3=Citrus, 4a=Roughage-dried, 4b=Roughage-silage, 
5=Other. – indicates that no data was available for this VOC in the feed ingredient category. ACT=Acetone, 
BNZ=Benzene, CHX=Cyclohexane, EAC=Ethylacetate, EBZ=Ethylbenzene, HEP=Heptane, HEX=Hexane, 
HXE=1-Hexene, OCT=Octane, PEN=Pentane, TOL=Toluene, OXL=O-Xylene, M+PXL=M+P Xylene. 
Feed 
ingredient 
category ACT BNZ CHX EAC EBZ HEP HEX HXE OCT PEN TOL OXL 
M+ 
PXL 
1  1700 - 890 - - 16 10650 - - 30 15 - - 
2a 6416 78 12411 2800 239 5359 42688 920 460 12140 2141 2400 2781 
2b 3500 - 2029 117 - 958 3565 - - 6382 - 503 3322 
3 - - - - - - - - - - - - - 
4a - - - - - - - - - - - - - 
4b - - - - - - - - - - - - - 
5 7650 - - - - - 1064 - - 2634 - - - 
5.6 Commodity limits 
There are no EU- or national limits for the discussed VOCs in feed and feed ingredients. The limits for 
VOCs in foods can be found in Annex VIII. 
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5.7 Transfer from animal feed to products for human consumption  
No data on carry-over of VOCs from feed to animal products were available.  
 
The disposition of these compounds in animal tissues (residue formation) following oral exposure of 
farm animals with feed is expected to be limited, as all compounds are rapidly glucuronidated in the 
liver (pers. comm. Prof Fink-Gremmels). Clearance of VOCs from the body is thought  to be a three-
step process, with VOCs stored in fatty tissue to be cleared in the last phase (EHP, 1996). The latter 
indicates that storage in fat tissue might occur, which can result in intake of stored VOCs following 
consumption of animal fat. 
5.8 Initial risk assessment 
No data were available on carry-over of VOCs from feed to animal products. For evaluation of any 
potential risk for humans of VOCs present in feed, worst case scenarios were calculated.  
For this, the measured maximum concentrations in feed ingredients were used to calculate a total 
intake of VOCs by food producing animals. This intake was estimated using feeding regimes and 
composition of compound feeds as described by Van Raamsdonk et al. (2006). Carry-over from this 
intake via feed was assumed to be 100% to each separate edible tissue in cow, pig and chicken. The 
intake of each VOC by humans via each separate edible tissue was calculated using the standard  
consumption parameters for the evaluation of veterinary drugs of the European Medicines Agency 
(EMEA, 2005). See for more details on the method used  ANNEX VIII. The results of the calculations 
on intake via animal products from cattle, pigs and poultry are given in ANNEX X-ANNEX XII. 
5.8.1 Human health 
The results of the calculations showed that the identified toxicological safety limits were not exceeded 
by the calculated intake of VOCs via animal products even when 100% carry-over was assumed of 
maximum measured concentrations (see table 4 and 5 and ANNEX X to ANNEX XII). It should be 
noted that not for all VOCs measured in feed ingredients, toxicological reference values were 
identified. This conclusion can therefore only be applied to the VOCs mentioned in table 2 and 5. In 
addition, not all feed ingredient categories were included in the National Control Plan for Animal Feed 
(see ANNEX IX Processing of VOC data), resulting in a potential underestimation of the calculated 
intake of VOCs. On the other hand it needs to be stressed that the carry-over rate from VOCs is 
expected to be much lower than 100%, partly due to their fast metabolisation.  
 
This conclusion might be less valid for the risk of carry-over of metabolites (especially relevant for the 
compounds hexane and benzene). As shown in the toxicological profile on hexane, the metabolite 2,5-
hexanedione induces neurotoxic effects in rats at oral doses which are 7 times lower (based on mols) 
than its parent compound n-hexane (5 times based on weight). When the provisional RfD of 0.06 
mg/kg bw/day is adjusted to 0.01 mg/kg bw/day based on this data, the ratio between the calculated 
hexane intake and this RfD might be less than 1 for some tissues such as milk, pig and chicken kidney 
and eggs (currently 1-10, see table 5). Even though an assumed carry-over of 100% for VOCs from 
feed to animal products is not realistic, the ratio of less than 1 between the adjusted provisional RfD an 
calculated intake for the metabolite 2,5-hexanedione indicates that special attention might be given to 
the possible carry-over of metabolites of VOCs. 
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From the results of the worst case calculations it is shown that based on the available information on 
toxicology and carry-over, risk from VOCs present in animal feed cannot be fully excluded. For the 
carry-over of parent compounds for which toxicological reference values are available, no risk is 
expected, but attention should be given to the metabolites of some of the VOCs. 
 
Table 4:  Overview of calculated intakes of VOCs by humans per animal product. Results are based on an 
estimated carry-over of 100% from maximum measured concentrations of VOCs in animal feed to each separate 
animal product, and food intake standards from the EMEA Standard Food Basket (EMEA, 2005). Calculated 
intake and reference values are expressed in µg/kg bw/day. ACT=Acetone, BNZ=Benzene, CHX=Cyclohexane, 
EAC=Ethylacetate, EBZ=Ethylbenzene, HEP=Heptane, HEX=Hexane, HXE=1-Hexene, OCT=Octane, 
PEN=Pentane, TOL=Toluene, OXL=O-Xylene, M+PXL=M+P Xylene. 
  ACT BNZ CHX EAC EBZ HEP HEX HXE OCT PEN TOL OXL 
M+ 
PXL 
 RfD/TDI 900 3.3  900 100  60    80 150 150 
Cattle                             
Milk summer 2.1 < 0.1 1.0 < 0.1 < 0.1 < 0.1 11.8 < 0.1 < 0.1 0.2 < 0.1 < 0.1 < 0.1 
 winter 7.2 < 0.1 3.4 < 0.1 < 0.1 0.1 40.0 < 0.1 < 0.1 0.6 0.1 < 0.1 0.1 
Meat  < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 0.2 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
Fat  < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
Liver  0.3 < 0.1 0.1 < 0.1 < 0.1 < 0.1 1.5 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
Kidney  1.2 < 0.1 0.6 < 0.1 < 0.1 < 0.1 6.6 < 0.1 < 0.1 0.1 < 0.1 < 0.1 < 0.1 
               
Pig                             
Meat  0.2 < 0.1 0.1 < 0.1 < 0.1 < 0.1 0.7 < 0.1 < 0.1 0.1 < 0.1 < 0.1 < 0.1 
Fat  < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
Liver  0.8 < 0.1 0.4 < 0.1 < 0.1 0.1 3.5 < 0.1 < 0.1 0.4 < 0.1 < 0.1 0.2 
Kidney  4.1 < 0.1 1.8 < 0.1 < 0.1 0.3 16.9 < 0.1 < 0.1 1.8 < 0.1 0.1 0.8 
               
Chicken                             
Meat  0.5 < 0.1 0.4 0.1 < 0.1 0.1 2.4 < 0.1 < 0.1 0.4 < 0.1 0.1 0.1 
Fat unknown              
Liver  2.5 < 0.1 1.9 0.3 < 0.1 0.6 11.2 0.1 < 0.1 1.9 0.2 0.3 0.6 
Kidney  1.3 < 0.1 1.0 0.1 < 0.1 0.3 5.9 < 0.1 < 0.1 1.0 0.1 0.1 0.3 
Egg  10.7 < 0.1 1.6 < 0.1 < 0.1 0.3 15.0 < 0.1 < 0.1 4.4 < 0.1 0.1 0.9 
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Table 5:  Ratio between RfD and calculated intake by humans per compound per animal product. RfDs are given 
in µg/kg bw/day. Ratios are classified based on orders of magnitude of 10. Only VOCs for which a reference 
value is derived are presented. Intake via chicken fat could not be calculated because of unknown fat percentage. 
Ratios for benzene and ethylbenzene in egg could not be calculated since data were only available in vegetable 
oil, which is not used as ingredient for compound feed for chickens (Raamsdonk et al., 2006). ACT=Acetone, 
BNZ=Benzene, EAC=Ethylacetate, EBZ=Ethylbenzene, HEX=Hexane, TOL=Toluene, OXL=O-Xylene, 
M+PXL=M+P Xylene. 
  ACT BNZ EAC EBZ HEX TOL OXL M+PXL 
 RfD/TDI 900 3.3 900 100 60 80 150 150 
Cattle                   
Milk summer 100 - 1000 > 1000 > 1000 > 1000 1 - 10 > 1000 > 1000 > 1000 
 winter 100 - 1000 > 1000 > 1000 > 1000 1 - 10 > 1000 > 1000 > 1000 
Meat  > 1000 > 1000 > 1000 > 1000 100 - 1000 > 1000 > 1000 > 1000 
Fat  > 1000 > 1000 > 1000 > 1000 100 - 1000 > 1000 > 1000 > 1000 
Liver  > 1000 > 1000 > 1000 > 1000 10 - 100 > 1000 > 1000 > 1000 
Kidney  100 - 1000 > 1000 > 1000 > 1000 1 - 10 > 1000 > 1000 > 1000 
          
Pig                   
Meat  > 1000 > 1000 > 1000 > 1000 10 - 100 > 1000 > 1000 > 1000 
Fat  > 1000 > 1000 > 1000 > 1000 100 - 1000 > 1000 > 1000 > 1000 
Liver  > 1000 > 1000 > 1000 > 1000 10 - 100 > 1000 > 1000 100 - 1000 
Kidney  100 - 1000 > 1000 > 1000 > 1000 1 - 10 > 1000 > 1000 100 - 1000 
          
Chicken                   
Meat  > 1000 > 1000 > 1000 > 1000 10 - 100 > 1000 > 1000 > 1000 
Fat unknown         
Liver  100 - 1000 100 - 1000 100 - 1000 100 - 1000 1 - 10 100 – 1000 100 - 1000 100 - 1000 
Kidney  100 - 1000 100 - 1000 100 - 1000 100 - 1000 10 - 100 100 – 1000 100 - 1000 100 - 1000 
Egg  10 - 100 - 100 - 1000 - 1 - 10 100 – 1000 100 - 1000 100 - 1000 
 
5.8.2 Animal health 
To obtain an indication on the risk of VOCs in feed for farm animals, the intake per animal species 
(based on maximum measured concentrations VOCs in feed ingredients) was taken from the worst 
case scenarios (see human health). The calculated intakes were then compared to the NOAELs in 
experimental animals from which the reference values for humans were derived. These NOAELs are 
summarized in table 2. 
 
The ratios between NOAELs and calculated intake were determined (table 6). The results show that 
the NOAELs are not exceeded, but in some cases ratios are less than 100. This value is usually applied 
as uncertainty factor for inter- and intraspecies variation in the derivation of a toxicological reference 
value. This indicates that if farm animals are more sensitive to the toxic effects of VOCs, a animal 
health problem might occur. However, it should be noted that the NOAELs are determined from 
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chronic toxicity studies, which might be less relevant in the case of farm animals. Contamination of 
animal feed can be expected to occur batch-wise. Feeding of a contaminated batch may thus result in a 
semi-chronic exposure.  
 
Table 6:  Ratio between NOAELs  and calculated intake by farm animals per compound.  Ratios are classified in 
orders of magnitude of 10. Only VOCs for which a reference value is derived are presented. Ratios for benzene 
and ethylbenzene for egg-laying chickens could not be calculated since data were only available in vegetable oil, 
which is not used as ingredient for compound feed for chickens (Raamsdonk et al., 2006). ACT=Acetone, 
BNZ=Benzene, EAC=Ethylacetate, EBZ=Ethylbenzene, HEX=Hexane, TOL=Toluene, OXL=O-Xylene, 
M+PXL=M+P Xylene. 
  ACT BNZ EAC EBZ HEX TOL OXL M+PXL 
Cattle milk summer 100 - 1000 >1000 >1000 >1000 100 - 1000 >1000 >1000 >1000 
milk winter 10 - 100 >1000 >1000 >1000 10 - 100 >1000 >1000 100 - 1000 
meat 100 - 1000 >1000 >1000 >1000 100 - 1000 >1000 >1000 >1000 
Pig  10 - 100 >1000 >1000 >1000 10 - 100 >1000 100 - 1000 10 - 100 
Chicken meat 10 - 100 1 - 10 100 - 1000 100 - 1000 10 - 100 10 - 100 10 - 100 10 - 100 
 egg 10 - 100 - >1000 - 10 - 100 >1000 100 - 1000 10 - 100 
 
Formation of reactive metabolites from the parent compounds, may pose a risk for the food producing 
animals. The half life of the VOCs benzene, toluene and styrene have been shown to be less than 24 
hours (Brugnone et al., 1986, 1992, 1993, cited by Ashley et al, 1996), indicating that production of 
VOC metabolites occurs rapidly after ingestion of VOCs. 
5.9 Discussion 
The Dutch Food and Consumer Product Safety Board (VWA) has the incentive to include certain 
contaminants in the yearly National Control Plan for Animal Feed (Regulation 882/2004), if risk 
assessments give rise to concern. Up to recent years, VOCs were included in the National Control 
Plan, but there is no legal obligation to monitor VOCs. The current (initial) risk assessment was 
undertaken to provide material for the discussion on whether or not to include VOCs in this National 
Control Plan. 
 
For this risk assessment, VOCs can be categorised in aromates (BTEX), alkanes (regular and specific) 
and other compounds (acetone and ethylacetate). From the toxicological profile, it can first be 
concluded that not for all VOCs, an oral reference value is available. Due to their volatile nature, 
mostly inhalation studies are performed on VOCs, while in this risk assessment, oral data are relevant. 
The lack of oral date is additionally illustrated by the fact that some of the oral reference values are 
derived by route-to-route extrapolation from inhalation data. Due to the limited availability of oral 
toxicological studies, not on all VOCs measured in feed ingredients a full risk assessment could be 
performed. 
It can be concluded that of the compounds for which oral toxicological studies were available, benzene 
and to a lesser extend ethylbenzene, is the most toxic compound. It is classified by IARC as 
carcinogenic to humans, based on induced leukaemia via toxicity to bone marrow. 
The compound which is present in the highest concentration in feed ingredients is hexane (during the 
years 2001-2004). It is this compound that is the most commonly used extraction solvent for vegetable 
oil. The measured concentrations of hexane in the National Control Plan for Animal Feed reached up 
to 42 mg/kg in soy oil.  
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Although no data on carry-over from feed to animal products are available, some concentrations in 
animal tissues or products of animal origin in food have been found. In a US survey (Fleming-Jones et 
al. 2003), concentrations in the range from 24 to 5328 ppb (µg/kg) were found in 70 foods, including 
animal products. The source of the VOCs was not identified. In the EU draft Risk Assessment (2003) 
it was concluded that ‘Drinking water and fish consumption contribute represent 0.1 - 2% to the total 
exposure. All other sources of exposure (milk, meat and vegetables) can be regarded not significant.’ 
5.9.1 Human health 
The results from our initial risk assessment support this conclusion. It should be noted that not all feed 
ingredient categories were included in the monitoring program. Using the limited data, a worst case 
scenario assuming 100% carry-over of VOCs from feed to single animal products was used to 
calculate potential intakes. For all measured VOCs in feed, including the most toxic and most present 
(benzene and hexane), risks for human health effects were not expected. The calculated intake using 
the maximum concentrations measured in the National Control Plan for Animal Feed resulted in 
intakes far below the RfDs. Even the calculated concentrations of benzene in milk (0.0024 and 0.0082 
µg/kg in summer and winter respectively, see ANNEX II) did not exceed the range of 1–10 µg/l in 
drinking water for 10-6 carcinogenic risk as derived by US-EPA in 2000. 
Additional to this low calculated risk using 100% carry-over, it is not very likely that carry-over of 
parent compounds from feed to animal products occurs, due to rapid metabolism of the compounds. 
However, it is not known to what extent (toxic) metabolites are formed and carried over to animal 
products, excretion via milk might be a possibility. The ingestion of metabolites from VOCs might be 
especially relevant in the case of benzene, ethylbenzene and hexane, because the metabolites of these 
compounds are regarded as the major cause of the corresponding toxicity. In the case of hexane, 
adjusting the provisional RfD to the higher toxicity of its metabolite 2,5-hexanedione, results in a ratio 
of less than 1 between the calculated intake and this RfD for some animal products such as milk, pig 
and chicken kidney and eggs.  
5.9.2 Animal health 
To assess a possible risk from the measured VOCs in feed ingredients for food producing animals, the 
ratios between NOAELs for toxicity in rats and the calculated intake by farm animals were 
determined. In some cases, these ratios were less than 100. It should be noted that NOAELs derived 
from chronic toxicity studies may be less relevant for food producing animals. Considering however, 
that nothing is known about the sensitivity of farm animals as compared to laboratory experimental 
animals, these ratios indicate that animals health effects from the VOCs in feed ingredients cannot be 
excluded.  
In addition, some VOCs, like pentane, are known to be toxic to paunch flora in cattle, resulting in 
disturbed digestion and reduced uptake of feed (pers. comm. Prof. Fink-Gremmels). A possible side 
effect of the concentrations of VOCs present in feed materials could also be an adverse taste, resulting 
in a reduced feed consumption (and weight gain losses).  
 
The concentrations of VOCs are measured in crude animal feed ingredients. Due to the volatile nature 
of the compounds, it can be expected that concentrations present in feed materials are reduced during 
processing of the materials for the production of compound feed, reducing any possible risk of intake 
for animals or humans. In order to be able to make a more accurate intake assessment, it might be 
useful to measure VOCs in compound feed.  
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5.9.3 Regulating VOCs 
This risk assessment does bring a complicated issue to light. In regulation 1831/2003 (additives for use 
in animal nutrition) the extraction solvents classify as processing aids. This means that compounds can 
be used in the production of animal feed, as long as residues in feed do no pose a risk for animals or 
humans. However, if the latter cannot be assessed because of lack of data on toxicology and/or carry-
over from feed to animal products, a risk cannot be excluded. This lack of proof for negative effects on 
humans or farm animals can result in current practice that compounds are being used, and thus may 
pose an unidentified risk. As regards processing aids, the question may therefore be posed if the 
Regulation is fully effective in protecting human and/or animal health. 
5.10 Conclusions and recommendations 
- Of all measured VOCs in the National Control Plan for Animal Feed, benzene is the most toxic 
compound and hexane is the most abundant compound; 
 
- A worst case scenario using 100% carry-over of  maximum measured concentrations of VOCs from 
feed to animal products does not result in calculated intake by humans above known reference limits. 
Risk from intake of the resulting metabolites cannot be excluded; 
 
- A quantitative risk assessment for food producing animals indicates that animal health effects may 
occur; 
 
- Due to the fact that VOCs concentrations in feed ingredients might be reduced during processing of 
compound feed, it may be useful to measure concentrations in compound feed as end product; 
 
- In absence of oral toxicity data, the (lack of) risk of the use of processing aids according to regulation 
1831/2003 cannot be assessed; 
 
- Based on the worst case scenario, inclusion of VOCs in the National Control Plan for Animal Feed is 
not recommended. The carry-over of possible metabolites to animal products remains a point of 
interest.  
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ANNEX I Processing of PAH data 
 
1. PAH concentrations have been measured in several feed ingredients in the years 2000-2004;  
2. These ingredients were categorised; 
3. Maximums and medians were calculated per category;  
4. These maxima were then used to calculate possible PAHs concentrations in mixed feed using the 
composition of mixed feed as provided by Kemme and Van Raamsdonk (2004);  
5. With the calculated maximum concentrations in mixed feed and measured maximum 
concentrations in rough feed, a maximum PAHs intake for cattle was calculated for several 
scenarios of feed consumption of cattle;  
6. Transfer rates of PAHs from feed to milk were taken from literature. In addition, transfer rates for 
native PAHs are calculated from the study of Kan et al. (2004); 
7. Using these transfer rates, maximum PAH concentrations in milk were calculated for several 
scenarios; 
8. Human intake is calculated using the standard food basket (1.5 l milk/day) from EMEA; 
9. Calculated human intake is compared to the known toxicological reference values. 
Please note that all data is standardised for 12% water content of the product 
 
Ad 1- Categories differ in number of samples analysed (see table A1). 
 
Table A1:  Specification of feed ingredients per category. 
Category Matrix # samples (n) 
1-Flakes copra extraction pellets 8 
2-Oils/fats animal fat 
destruction fat 
frying fat 
linolic fatty acids 
palm oil 
palm oil fatty acids 
vegetable oil/fat 
poultry fat 
soy oil 
tall oil sterols 
pork fat 
 
15 
9 
5 
1 
2 
1 
8 
2 
5 
27 
1 
3-Citrus citrus pulp pellets 9 
4-Roughage-dried dried grass 
grass pellets 
lucerne pellets 
1 
68 
39 
4a-Roughage-silage grass silage 2 
5-Other potatoe 
beet 
beans 
cabbage 
lettuce 
onion 
3 
2 
2 
2 
1 
1 
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Ad 2- Maxima and medians of PAH concentrations measured in the feed ingredients in the National 
Control Plan for Animal Feed are specified in tables A2 and A3. 
 
Table A2:  Maximum concentrations PAHs in feed categories in µg/kg. ACE=Acenaphthene, 
ACY=Acenaphthylene, BAA=Benz[a]anthracene, BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, 
BKF=Benzo[k]fluoranthene, CHR=Chrysene, DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, 
FLU=Fluoranthene, IDP=Indeno[1,2,3-c,d]pyrene, PYR=Pyrene. In citrus, no usable data was obtained for 
DBA, PHE, FLU and PYR  due to conversion errors from Gas chromatograph. For these PAHs, the detection 
limit was taken as maximum concentration. 
Category  ACE ACY BAA BAP BBF BKF CHR DBA PHE FLU IDP PYR 
1 Flakes Flakes 34.78 2.00 3.17 2.00 1.74 0.38 4.79 0.14 76.16 15.83 1.10 31.87 
2 
Oils/fats Oils/fats 9.20 6.50 7.60 9.80 9.50 7.20 9.00 6.30 9.00 9.60 9.10 9.50 
3 Citrus Citrus 5.30 2.50 7.60 9.60 6.50 2.40 9.20 0.10 0.10 0.10 6.90 0.10 
4 
Roughage 
dried 
Roughage 
dried 13.36 12.94 14.30 9.80 10.18 8.80 15.07 8.40 80.80 157.40 8.50 98.20 
4a 
Roughage 
silage 
Roughage 
silage 1.20 1.80 8.20 7.90 9.10 4.30 0.72 1.20 3.90 2.70 5.40 1.90 
5 Other 1.10 0.66 6.00 7.30 6.00 3.10 5.30 0.88 5.10 4.60 5.00 2.90 
 
Table A3:  Median concentrations PAHs in feed categories in µg/kg. ACE=Acenaphthene, ACY=Acenaphthylene, 
BAA=Benz[a]anthracene, BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, 
CHR=Chrysene, DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene.  
Category  ACE ACY BAA BAP BBF BKF CHR DBA PHE FLU IDP PYR 
1 Flakes 6.03 1.78 2.11 0.99 0.97 0.28 2.53 0.13 67.72 14.49 0.83 19.52 
2 Oils/fats 2.95 2.50 1.90 1.50 1.40 0.65 2.30 0.99 3.40 4.50 1.15 7.45 
3 Citrus 4.20 2.05 5.75 5.55 5.20 1.85 9.15 0.00 0.00 0.00 4.45 0.00 
4 
Roughage 
dried 0.89 1.35 1.60 1.60 1.95 1.40 2.90 1.20 5.40 4.60 1.70 3.75 
4a 
Roughage 
silage 1.00 1.80 8.20 7.90 4.92 4.30 0.72 1.20 3.90 2.70 5.40 1.90 
5 Other 0.89 0.20 0.61 0.29 0.36 0.40 0.25 0.52 2.00 0.58 0.27 0.44 
 
In the National Control Plan for Animal Feed, no fresh grass samples were analysed. However fresh 
grass is a major part of the consumption of roughage by cows during summer. Therefore from 
literature, PAH concentrations in fresh grass were taken. These were applied in Summer scenario 2 
(see Ad 4). PAH concentrations in fresh grass were taken from Crépineau-Ducoulombier et al. (2004, 
control site 2), where concentrations lower than detection limit were assumed to be at the level of 
detection of 0.50 µg/kg. 
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Table A4:  PAH concentrations in fresh grass in µg/kg. Data taken from Crépineau-Ducoulombier et al. (2004, 
control site 2). Concentrations lower than detection limit were assumed to be at the level of detection of 0.50 
µg/kg. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, BAP=Benzo[a]pyrene, 
BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, DBA=Dibenzo[a,h]anthracene, 
PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-c,d]pyrene, PYR=Pyrene. 
 ACE ACY BAA BAP BBF BKF CHR DBA PHE FLU IDP PYR 
Fresh grass 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 34.54 18.22 0.50 31.62 
 
Ad 3- Contribution of individual feed ingredient categories to compound feed of cattle (Kemme en Van 
Raamsdonk, 2004). Not all ingredients for compound feed were represented in the samples from the 
National Control Plan for Animal Feed, explaining why the sum of the percentages of contribution of 
individual feed ingredient categories is less than 100%. It may be possible that PAHs in the ingredients 
not represented here might have added to the calculated PAH content of compound feed. For this 
initial risk assessment it is assumed that all PAHs in the concentrate originate only from the feed 
ingredients listed in table A5. 
 
Table A5:  Contribution of feed ingredient categories to compound feed of cattle (from Kemme en Van 
Raamsdonk, 2004) 
Category Average % 
1 Flakes 57 
2 Oils/fats 0.4 
3 Citrus 3.5 
4 Roughage 0.4 
5 Other 1.6 
 
Ad 4- Specification of the applied feeding regimes in the scenarios used in this report. The PAH 
concentration in corn silage was assumed to be the same as in grass silage, thus mais and grass silage 
were used as one feeding category. Scenarios were derived from Van Raamsdonk et al., 2006 (in 
preparation). Results from the scenarios are presented in Appendices B-G. 
 
Table A6:  Applied feeding regimes in the scenarios used for risk assessment. Feed is in kg per cow per day. * 
lack of PAH monitoring data is represented as 0 kg of grass consumption. 
 Compound feed Roughage-silage Roughage-dried Fresh grass 
Winter scenario 1 7.1 11.9 0 0 
Winter scenario 2 7.1 5.95 5.95 0 
Winter scenario 3 7.1 0 11.9 0 
Summer scenario 1 2.1 6.5 0 0* 
Summer scenario 2 2.1 6.5 0 7.9 
Scenario ASG 1 11.3 10 0 
 
Ad 5- Transfer rates of PAHs from feed to milk were taken from literature (see table A7). Lutz et al. 
(2005) measured the concentration of native PAHs and their metabolites in milk of cows which were 
orally exposed to soil which contained PAHs. They found no transfer of native PAHs but did find 
metabolites in the milk. Grova et al., (2002) measured PAH related C14 activity in milk after oral 
exposure of goats to several labeled PAHs. No distinction was made between native compounds or 
their metabolites, so the measured activity can be related to both. 
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In addition, transfer rates for native PAHs are calculated from the study of Kan et al. (2004). For this, 
the total amount of PAHs consumed by the cows was calculated and compared to the measured 
concentrations in milk. In this comparison, the assumption was made that all measured PAHs 
originated from the PAH in the contaminated feed. This results in an overestimation of the transfer 
rate, because background concentrations in the milk are neglected. No metabolites were measured in 
this study, so transfer rates are limited to parent compounds.  
 
Table A7:  Transfer rates of PAHs from feed to milk in percentages. Data taken from literature and calculation. 
ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, BAP=Benzo[a]pyrene, 
BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, DBA=Dibenzo[a,h]anthracene, 
PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-c,d]pyrene, PYR=Pyrene. 
    ACE ACY BAA BAP BBF BKF CHR DBA PHE FLU IDP PYR 
Lutz 2005 
Native 
PAH       0         0   0 
 Metabolite       0         0.03     1.62 
Grova 
2002 PAH related C14   0.20     1.60   1.90 
Kan 2003 
Native 
PAH  1.35          0.05   3.21 0.44   0.39 
 
Metabolites not 
done                       
Applied in this Risk 
Assessment 1.35 1.90 0.20 0.20 0.20 0.20 0.05 0.20 3.21 1.90 0.20 1.90 
 
Using these transfer rates, maximum PAH concentrations in milk were calculated. For PAHs for which 
no transfer rates were available, the maximum of transfer rates for low- and high molecular PAHs was 
applied. Although pyrene was not classified as low-molecular PAH, its transfer rate (1.9%) was taken 
for this group because of similar transfer behaviour to the low-molecular PAHs. For high-molecular 
PAHs this was 0.2% (from Benzo(a)pyrene). Because of use of the total transfer rates from the PAH 
related activity in the study of Grova, no distinction was made for transfer of native compounds or 
metabolites in the evaluation.  
 
Ad 6- The milk production corresponding with the food regimes used in the scenarios was 27 liters for 
the winter- and summer scenarios (Van Raamsdonk et al., 2004), and 25 liters for the ASG scenario 
(Kan et al., 2003). Results from calculated transfer are summarized in the results from the scenarios in 
ANNEX II-ANNEX VII..  
 
Ad 7- Human PAH intake from milk is calculated using the standards for milk consumption (1.5 liters) 
and body weight (60 kg) as set by EMEA. 
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ANNEX II PAH Winter scenario 1 
 
Applied feeding regime in kg per cow per day. 
Compound feed 7.1 
Roughage dried 0 
Roughage silage 11.9 
Three winter scenarios were designed because of the relative high concentrations of PAHs in  
artificially dried grass pellets. The winter feeding regime as used by Van Raamsdonk et al. (2006, in 
preparation) for milk production of 27 liters was used as a basis for the winterscenarios. The amount 
of 0.97 kg moist compound feed as defined in the winter feeding regime of Van Raamsdonk et al. was 
not taken up in the winterscenarios because of lack of data from the National Control Plan for this 
feeding categorie. 
In the winterscenarios, the percentage of silage in the winter feeding regime is replaced in varying 
proportions by grass pellets to simulate this variety in feed sources. In this first scenario, all roughage 
is assumed to consist of silage. 
 
Results from calculation  
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addtion, the ratio between the reference value and the 
calculated intake is given.  
 * Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX III PAH Winter scenario 2 
 
Applied feeding regime in kg per cow per day. 
Compound feed 7.1 
Roughage dried 5.95 
Roughage silage 5.95 
Three winter scenarios were designed because of the relative high concentrations of PAHs in 
artificially dried grass pellets. The winter feeding regime as used by Van Raamsdonk et al. (2006, in 
preparation) for milk production of 27 liters was used as a basis for the winterscenarios. The amount 
of 0.97 kg moist compound feed as defined in the winter feeding regime of Van Raamsdonk et al. was 
not taken up in the winterscenarios because of lack of data from the National Control Plan for this 
feeding categorie. 
In the winterscenarios, the percentage of silage in the winter feeding regime is replaced in varying 
proportions by grass pellets to simulate this variety in feed sources. In this second scenario, roughage 
is assumed to consist of half grass pellets and half of silage. 
 
Results from calculation 
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addtion, the ratio between the reference value and the 
calculated intake is given.  
* Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX IV PAH Winter scenario 3 
 
Applied feeding regime in kg per cow per day. 
Compound feed 7.1 
Roughage dried 11.9 
Roughage silage 0 
Three winter scenarios were designed because of the relative high concentrations of PAHs in 
artificially dried grass pellets. The winter feeding regime as used by Van Raamsdonk et al. (2006, in 
preparation) for milk production of 27 liters was used as a basis for the winterscenarios. The amount 
of 0.97 kg moist compound feed as defined in the winter feeding regime of Van Raamsdonk et al. was 
not taken up in the winterscenarios because of lack of data from the National Control Plan for this 
feeding categorie. 
In the winterscenarios, the percentage of silage in the winter feeding regime is replaced in varying 
proportions by grass pellets to simulate this variety in feed sources. In this third scenario, all roughage 
is assumed to consist of grass pellets. 
 
Results from calculation 
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addtion, the ratio between the reference value and the 
calculated intake is given.  
* Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX V PAH Summer scenario 1 
 
Applied feeding regime in kg per cow per day. 
Compound feed 2.1 
Grass 0 
Roughage silage 6.5 
Two summerscenarios were designed because of the lack of data from fresh grass samples in the 
National Control Plan for Animal Feed. The summer feeding regime as used by Van Raamsdonk et al. 
(2006, in preparation) for milk production of 27 liters was used as a basis for the summerscenarios. 
The amount of 0.26 kg moist compound feed as defined in the summer feeding regime of Van 
Raamsdonk et al. was not taken up in the summerscenarios because of lack of data from the National 
Control Plan for this feeding categorie.The scenarios differ in the use of PAH concentrations in fresh 
grass, for one scenario no data are used (current situation National Control Plan), and for one scenario 
data is taken from literature. In this first summerscenario, no data for fresh grass were used, 
represented as consumption of 0 kg in the table above. 
 
Results from calculation 
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addtion, the ratio between the reference value and the 
calculated intake is given.  
* Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX VI PAH Summer scenario 2 
 
Applied feeding regime in kg per cow per day. 
Compound feed 2.1 
Grass 7.9 
Roughage silage 6.5 
Two summerscenarios were designed because of the lack of data from fresh grass samples in the 
National Control Plan for Animal Feed. The summer feeding regime as used by Van Raamsdonk et al. 
(2006, in preparation) for milk production of 27 liters was used as a basis for the summerscenarios. 
The amount of 0.26 kg moist compound feed as defined in the summer feeding regime of Van 
Raamsdonk et al. was not taken up in the summerscenarios because of lack of data from the National 
Control Plan for this feeding categorie.The scenarios differ in the use of PAH concentrations in fresh 
grass, for one scenario no data are used (current situation National Control Plan for Animal Feed), and 
for one scenario data is taken from literature. In this second summer scenario, data from fresh grass 
were used from the study of Crépineau-Ducoulombier et al. (2004, control site 2). 
 
Results from calculation 
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addtion, the ratio between the reference value and the 
calculated intake is given.  
 * Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX VII PAH Scenario ASG 
 
Applied feeding regime in kg per cow per day. 
Compound feed 1 
Roughage dried 11.3 
Roughage silage 10 
The feeding regime as used in the study of Kan et al. (2003) was used with the data from the National 
Control Plan for Animal Feed. The feeding regime was selected by Kan et al. to contain the highest 
possible amount of contaminated feed, in order to facilitate a maximum transfer rate of PAHs from the 
feed to milk. 
 
Results from calculation 
In the tables below an overview is given of calculated transfer of PAHs from feed to milk and 
calculated intakes by humans and cows. In addition, the ratio between the reference value and the 
calculated intake is given.  
 * Value is not an RfD but a ‘virtually safe dose’ calculated by US-EPA based on carcinogenic risk of 
1*10-6. ACE=Acenaphthene, ACY=Acenaphthylene, BAA=Benz[a]anthracene, 
BAP=Benzo[a]pyrene, BBF=Benzo[b]fluoranthene, BKF=Benzo[k]fluoranthene, CHR=Chrysene, 
DBA=Dibenzo[a,h]anthracene, PHE=Phenanthrene, FLU=Fluoranthene, IDP=Indeno[1,2,3-
c,d]pyrene, PYR=Pyrene. 
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ANNEX VIII VOCs allowed in food production 
 
List of VOCs which are currently allowed for use as extraction solvents in the production of foodstuffs 
and food ingredients following Directives 88/344/EEC, 92/115/EEC, 94/52/EEC and 97/60/EEC. The 
tables are taken from the Proposal for a directive of the European Parliament and of the Council on the 
approximation of the laws of the Member States on extraction solvents used in the production of 
foodstuffs and food ingredients (Codified version, COM[2003] 467 final 2003/0181 [COD]).  
 
Part I Extraction solvents to be used in compliance with good manufacturing practice for all uses1.3 
 
             88/344/EEC (adapted) 
          1  92/115/EEC Art. 1 pt. 3 
          2  97/60/EC art. 1 pt. 2 
Propane 
Butane 
Ethyl acetate 
Ethanol 
Carbon dioxide 
Acetone          1 2  
Nitrous oxide 
 
 
          3  94/52/EC Art. 1 
 
Part II Extraction solvents for which conditions of use are specified  
Name Conditions of use 
(summary description of 
extraction) 
Maximum residue limits in the 
extracted foodstuff or food 
ingredient 
        2 Hexane3           2 Production or 
fractionation of fats and 
oils and production of 
cocoa butter     
       2 1 mg/kg in the fat or oil or 
cocoa butter   
        2 Preparation of 
defatted protein products 
and defatted flours     
       2 10 mg/kg in the food 
containing the defatted protein 
products and the defatted 
 flours      
         2 30 mg/kg in the defatted 
soya products as sold to the 
final consumer     
        2 Preparation of 
defatted cereal germs     
       2 5 mg/kg in the defatted 
cereal germs     
Methyl acetate Decaffeination of, or 
removal of irritants and 
bitterings from coffee and 
tea 
20 mg/kg in the coffee or tea 
 Production of sugar from 1 mg/kg in the sugar 
                                                     
1 An extraction solvent is considered as being used in compliance with good manufacturing practice if its use 
results only in the presence of residues or derivatives in technically unavoidable quantities presenting no 
danger to human health. 
2  The use of Acetone in the refining of olive- pomace oil is forbidden. 
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molasses 
Ethylmethylketone        14  Fractionation of fats and 
oils 
5 mg/kg in the fat or oil 
 Decaffeination of, or 
removal of irritants and 
bitterings from coffee and 
tea 
20 mg/kg in the coffee or tea 
       1 Methanol           1 For all uses           1 10 mg/kg    
       1 Propan-2-ol           1 For all uses           1 10 mg/kg    
 
Part III Extraction solvents for which conditions of use are specified (preparation of flavourings from 
natural flavouring materials) 
 
Name Maximum residue limits in 
the foodstuff due to the use of 
extraction solvents in the 
preparation of flavourings 
from natural flavouring 
materials 
 
Diethyl ether 2 mg/kg  
Hexane       1 5    1 mg/kg  
       3 Cyclohexane            3 1 mg/kg      
Methyl acetate 1 mg/kg  
Butan-1-ol 1 mg/kg  
Butan-2-ol 1 mg/kg  
Ethylmethylketone       1 5     1 mg/kg  
Dichloromethane        1 0,02 mg/kg       
       1 Propan-1-ol            1 1 mg/kg    
       2 1,1,1,2-tetrafluoroethane            2 0,02 mg/kg      
 
 
4
                                                     
3 Hexane means a commercial product consisting essentially of acyclic saturated hydrocarbons containing 
six carbon atoms and distlling between 64 oC and 70 oC. 
 1The combined use of Hexane and Ethylmetylketone is forbidden.  
4 1The presence of n-Hexane in this solvent should not exceed 50 mg/kg. This solvent may not be used in 
combination with Hexane.  
5 The combined use of these two solvents is forbidden.  
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ANNEX IX Processing of VOC data 
 
VOC concentrations have been measured in several feed ingredients in the years 2000-2004.  
1. These ingredients were categorised; 
2. Maximum concentrations were calculated per category;  
3. These maximum concentrations were then used to calculate possible VOC concentrations in mixed 
feed for each food producing animal using the composition of mixed feed as provided by Kemme 
and Van Raamsdonk (2004);  
4. With the calculated maximum concentrations in mixed feed, a maximum VOC intake for cattle, pig 
and chickens was calculated in end-of-breed scenarios of feed consumption;  
5. Transfer rates of VOCs from feed to milk, meat, fat, liver, kidney and egg were assumed to be 
100%; 
6. Using these transfer rates, maximum VOC concentrations in foods were calculated; 
7. Human intake is calculated using the standard food basket (1.5 l milk/day, 0.3 kg meat/day, 0.05 kg 
fat/day, 0.1 kg liver/day, 0.05 kg pork kidney/day, 0.01 chicken kidney/day and 0.1 kg eggs/day) 
and standard body weight of 60 kg from EMEA; 
8. Calculated human intake is compared to the known toxicological reference values. 
 
Please note that all data were standardised for 12% water content of the product 
 
Ad 1- Categories differ in number of samples from which the results were used (see table A1). 
 
Table A1: Specification of feed ingredients per category. 
Category Matrix # samples (n) 
1-Flakes Soy 
Sunflower 
Reap 
Sesame 
Palm seed 
Unknown vegetable origin 
19 
11 
10 
1 
1 
1 
2a-Oils/fats- 
vegetable 
Soy 
Palm seed 
Coconut 
Unknown vegetable origin 
13 
15 
4 
3 
2b- Oils/fats- animal Unknown animal origen 6 
3-Citrus  None 
4a-Roughage-dried  None 
4b-Roughage-silage  None 
5-Other Soy lecithin 2 
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Ad 2- Details of VOC concentrations measured in the feed ingredients in the National Control Plan for 
Animal Feed are specified in tables A2, A3 and A4. Only results above the Limit of Detection (LOD) 
were used in the risk assessment.  
 
Table A2:  Statistics of results of all samples as measured in the National Control Plan for Animal 
Feed in the years 2000-2004. Positive result is a result above LOD. Concentrations in µg/kg. 
ACT=Acetone, BNZ=Benzene, CHX=Cyclohexane, EAC=Ethylacetate, EBZ=Ethylbenzene, 
HEP=Heptane, HEX=Hexane, HXE=1-Hexene, OCT=Octane, PEN=Pentane, TOL=Toluene, 
OXL=O-Xylene, M+PXL=M+P Xylene. 
  ACT BNZ CHX EAC EBZ HEP HEX HXE OCT PEN TOL OXL 
M+ 
PXL 
min ug/kg 16 18 0 11 36 16 11 920 460 0 12 30 35 
max ug/kg 7650 78 12411 2800 239 5359 42688 920 460 12140 2141 2400 3322 
med ug.kg 449 38 160 41 60 245 1012 920 460 1400 45 176 978 
No of 
samples  199 199 199 199 199 199 199 199 199 199 199 199 199 
# positives  48 6 39 10 5 24 60 1 1 25 13 13 6 
% positives  24 3 20 5 3 12 30 1 1 13 7 7 3 
 
Table A3:  Maximum concentrations in feed ingredient categories as measured in the National Control 
Plan for Animal Feed in the years 2000-2004. Concentrations in µg/kg. Feed ingredient categories 
are: 1=Flakes, 2a=Oils/fats-vegetable, 2b=Oils/fats-animal, 3=Citrus, 4a=Roughage-dried, 
4b=Roughage-silage, 5=Other. – indicates that no data was available for this VOC in the feed 
ingredient category. ACT=Acetone, BNZ=Benzene, CHX=Cyclohexane, EAC=Ethylacetate, 
EBZ=Ethylbenzene, HEP=Heptane, HEX=Hexane, HXE=1-Hexene, OCT=Octane, PEN=Pentane, 
TOL=Toluene, OXL=O-Xylene, M+PXL=M+P Xylene. 
Feed 
ingredient 
category ACT BNZ CHX EAC EBZ HEP HEX HXE OCT PEN TOL OXL 
M+ 
PXL 
1  1700 - 890 - - 16 10650 - - 30 15 - - 
2a 6416 78 12411 2800 239 5359 42688 920 460 12140 2141 2400 2781 
2b 3500 - 2029 117 - 958 3565 - - 6382 - 503 3322 
3 - - - - - - - - - - - - - 
4a - - - - - - - - - - - - - 
4b - - - - - - - - - - - - - 
5 7650 - - - - - 1064 - - 2634 - - - 
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Table A4:  Median concentrations in feed ingredient categories as measured in the National Control 
Plan for Animal Feed in the years 2000-2004. Concentrations in µg/kg. Feed ingredient categories 
are: 1=Flakes, 2a=Oils/fats-vegetable, 2b=Oils/fats-animal, 3=Citrus, 4a=Roughage-dried, 
4b=Roughage-silage, 5=Other. – indicates that no data was available for this VOC in the feed 
ingredient category. ACT=Acetone, BNZ=Benzene, CHX=Cyclohexane, EAC=Ethylacetate, 
EBZ=Ethylbenzene, HEP=Heptane, HEX=Hexane, HXE=1-Hexene, OCT=Octane, PEN=Pentane, 
TOL=Toluene, OXL=O-Xylene, M+PXL=M+P Xylene. 
Feed 
ingredient 
category ACT BNZ CHX EAC EBZ HEP HEX HXE OCT PEN TOL OXL 
M+ 
PXL 
1  327 - 158 - - 16 1450 - - 14 15 - - 
2a 220 38 1200 38 60 209 801 920 460 1600 128 153 288 
2b 1100 - 2029 117 - 410 390 - - 1400 - 503 3322 
3              
4a              
4b              
5 4036 - - - - - 821 - - 2634 - - - 
  
Ad 3- The contribution of individual feed ingredient categories to compound feed of the food 
producing animals are given in ANNEX X - ANNEX XII and taken from Kemme en Van Raamsdonk, 
2004. Not all ingredients for compound feed were represented in the samples from the National 
Control Plan for Animal Feed, explaining why the sum of the percentages of contribution of individual 
feed ingredient categories is less than 100%. It may be possible that VOCs in the ingredients not 
represented here might have added to the calculated VOC content of compound feed. For this initial 
risk assessment it is assumed that all VOCs in the concentrate originate only from the feed ingredients 
listed in the respective Annexes. 
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